syndrome	score	normalized_score
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	100.0
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.206092931	20.59814087516551
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.200541419	20.043290081927132
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	19.98917747951822
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.2	19.98917747951822
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2	19.98917747951822
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.14746345899999996	14.738366268473287
CITRULLINEMIA TYPE II	0.14339841899999997	14.332082238366583
CHRONIC HICCUP	0.14285699999999998	14.27796963595767
BRAIN-LUNG-THYROID SYNDROME	0.14285699999999998	14.27796963595767
LEPTIN DEFICIENCY OR DYSFUNCTION	0.14285699999999998	14.27796963595767
1P21.3 MICRODELETION SYNDROME	0.14285699999999998	14.27796963595767
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.14285699999999998	14.27796963595767
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.0242331	2.421998683894565
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.023961851000000003	2.3948884618838555
2P15P16.1 MICRODELETION SYNDROME	0.022191798000000002	2.2179789440580873
BECKWITH-WIEDEMANN SYNDROME	0.02016806	2.015714653787861
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.019386681000000003	1.9376190362390189
DISTAL MONOSOMY 10Q	0.018935273000000002	1.892502663100647
SOTOS SYNDROME	0.018425143	1.841517267562514
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.018367761000000003	1.8357821726518655
MALAN OVERGROWTH SYNDROME	0.017900209	1.7890522731073468
MARSHALL-SMITH SYNDROME; MRSHSS	0.017316212	1.7306841747048156
CLARK-BARAITSER SYNDROME	0.016896093	1.688695008437227
ATKIN-FLAITZ SYNDROME	0.016371159	1.63623001398206
CRANIOFACIOFRONTODIGITAL SYNDROME	0.015829740000000002	1.5821174115731438
TEMPLE SYNDROME	0.014958988000000001	1.4950893302299164
PHELAN-MCDERMID SYNDROME	0.014796707000000001	1.478870011677148
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.014796707000000001	1.478870011677148
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.014360103	1.43523323745581
DISTAL TRISOMY 15Q	0.014360103	1.43523323745581
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.014072019000000002	1.4064404264307626
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.014029440999999998	1.4021849304371474
NOONAN SYNDROME 7; NS7	0.014029440999999998	1.4021849304371474
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.014029440999999998	1.4021849304371474
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.014029440999999998	1.4021849304371474
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.013818684000000001	1.3811206350468939
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.013792591000000002	1.3785127470070284
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.013792591000000002	1.3785127470070284
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.013792591000000002	1.3785127470070284
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.013792591000000002	1.3785127470070284
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.013534753	1.3527428992922081
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.0135306	1.3523278240218461
HEART AND BRAIN MALFORMATION SYNDROME	0.013504507	1.3497199359819807
BOHRING-OPITZ SYNDROME	0.013504507	1.3497199359819807
8Q24.3 MICRODELETION SYNDROME	0.013504506999999999	1.3497199359819805
48,XYYY SYNDROME	0.013293750000000002	1.3286556405917267
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.013293750000000002	1.3286556405917267
17P13.3 MICRODUPLICATION SYNDROME	0.013293750000000002	1.3286556405917267
MARFAN SYNDROME; MFS	0.013293750000000002	1.3286556405917267
MOSAIC TRISOMY 8	0.013293750000000002	1.3286556405917267
LOEYS-DIETZ SYNDROME 5	0.013293750000000002	1.3286556405917267
LOEYS-DIETZ SYNDROME	0.013293750000000002	1.3286556405917267
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.013267657	1.3260477525518612
COHEN-GIBSON SYNDROME; COGIS	0.013251172	1.324400144598112
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.013067902999999999	1.3060831617606425
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.012963088000000001	1.2956073335730642
OSTEOGENESIS IMPERFECTA, TYPE X	0.012963088	1.2956073335730642
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.012963088	1.2956073335730642
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.012963088	1.2956073335730642
47,XYY SYNDROME	0.012831053000000002	1.2824109783305235
CHIME SYNDROME	0.012831053000000002	1.2824109783305235
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.012831053000000002	1.2824109783305235
48,XXYY SYNDROME	0.012831053000000002	1.2824109783305235
AUTISM, SUSCEPTIBILITY TO, 18	0.012831053000000002	1.2824109783305235
MONOSOMY 9Q22.3	0.012831053000000002	1.2824109783305235
SIMPSON-GOLABI-BEHMEL SYNDROME	0.012831053000000002	1.2824109783305235
EHLERS-DANLOS SYNDROME, TYPE VI	0.012726238	1.2719351501429448
JOUBERT SYNDROME 32; JBTS32	0.012726238	1.2719351501429448
SILVER-RUSSELL SYNDROME	0.012468400000000001	1.246165302428125
GABA-TRANSAMINASE DEFICIENCY	0.012306119	1.2299459838753564
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.012306119	1.2299459838753564
NEUROFIBROMATOSIS TYPE 1	0.012306119	1.2299459838753564
TRISOMY X	0.012306119	1.2299459838753564
48,XXXY SYNDROME	0.012306119	1.2299459838753564
KLIPPEL-TRÃ‰NAUNAY SYNDROME	0.012289634	1.228298375921607
SUMMITT SYNDROME	0.012289634	1.228298375921607
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.012289634	1.228298375921607
WEAVER SYNDROME	0.012289634	1.228298375921607
PERLMAN SYNDROME	0.012289634	1.228298375921607
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.012289634	1.228298375921607
DYSMORPHISM-CLEFT PALATE-LOOSE SKIN SYNDROME	0.012289634	1.228298375921607
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.01200155	1.1995055648965594
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.01200155	1.1995055648965594
TEEBI-SHALTOUT SYNDROME; TBSH	0.01200155	1.1995055648965594
EMANUEL SYNDROME	0.011960301	1.1953828969872962
SOMATOMAMMOTROPINOMA	0.011764700000000001	1.17583338146644
TRIM32-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R8	0.011764700000000001	1.17583338146644
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.011764700000000001	1.17583338146644
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.011764700000000001	1.17583338146644
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.011764700000000001	1.17583338146644
PREMATURE OVARIAN FAILURE 2B	0.011764700000000001	1.17583338146644
ACROCALLOSAL SYNDROME	0.011764700000000001	1.17583338146644
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20; BMIQ20	0.011764700000000001	1.17583338146644
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.011764700000000001	1.17583338146644
612917 GIACHETI SYNDROME;;MARFANOID HABITUS AND SPECIFIC LANGUAGE AND LEARNING DISABILITIES	0.011764700000000001	1.17583338146644
EPIPHYSEAL CHONDRODYSPLASIA, MIURA TYPE; ECDM	0.011764700000000001	1.17583338146644
ACROMEGALY	0.011764700000000001	1.17583338146644
AROMATASE DEFICIENCY	0.011764700000000001	1.17583338146644
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.011764700000000001	1.17583338146644
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.011764700000000001	1.17583338146644
MULTIPLE MYELOMA	0.011764700000000001	1.17583338146644
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.011764700000000001	1.17583338146644
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.011764700000000001	1.17583338146644
MGAT2-CDG	0.011764700000000001	1.17583338146644
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.011764700000000001	1.17583338146644
46,XY SEX REVERSAL 1; SRXY1	0.011764700000000001	1.17583338146644
46,XX SEX REVERSAL 1; SRXX1	0.011764700000000001	1.17583338146644
DIABETIC EMBRYOPATHY	0.011764700000000001	1.17583338146644
SCLEROSTEOSIS	0.011764700000000001	1.17583338146644
MCCUNE-ALBRIGHT SYNDROME	0.011764700000000001	1.17583338146644
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.011764700000000001	1.17583338146644
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.011764700000000001	1.17583338146644
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 1; EDSPD1	0.011764700000000001	1.17583338146644
CHROMOSOME XQ26.3 DUPLICATION SYNDROME	0.011764700000000001	1.17583338146644
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.011764700000000001	1.17583338146644
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.011764700000000001	1.17583338146644
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.011764700000000001	1.17583338146644
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.011493451	1.1487231594557308
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.011493451	1.1487231594557308
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.011493451	1.1487231594557308
SPINOCEREBELLAR ATAXIA 47; SCA47	0.011493451	1.1487231594557308
LATHOSTEROLOSIS	0.011493451	1.1487231594557308
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.011493451	1.1487231594557308
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.011493451	1.1487231594557308
INFANTILE SIALIC ACID STORAGE DISEASE	0.011435367	1.1429179025321292
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.010968517	1.0962581650005636
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.010968517	1.0962581650005636
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.010968517	1.0962581650005636
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.010968517	1.0962581650005636
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.010968517	1.0962581650005636
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.010952032	1.0946105570468145
VAN MALDERGEM SYNDROME 1; VMLDS1	0.010952032	1.0946105570468145
VAN MALDERGEM SYNDROME 2; VMLDS2	0.010952032	1.0946105570468145
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.010952032	1.0946105570468145
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.010893948	1.0888053001232127
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.010893948	1.0888053001232127
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.010531913	1.0526213907792257
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.010531913	1.0526213907792257
PRADER-WILLI-LIKE SYNDROME	0.010531913	1.0526213907792257
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.010473829	1.046816133855624
FG SYNDROME TYPE 1	0.010473829	1.046816133855624
CORNELIA DE LANGE SYNDROME	0.010473829	1.046816133855624
ZELLWEGER SYNDROME	0.010473829	1.046816133855624
ROBERTS SYNDROME	0.010457344	1.0451685259018748
CARDIOFACIOCUTANEOUS SYNDROME	0.010457344	1.0451685259018748
COSTELLO SYNDROME; CSTLO	0.010457344	1.0451685259018748
DIAMOND-BLACKFAN ANEMIA 1	0.010457344	1.0451685259018748
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.010431251	1.0425606378620096
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.010431251	1.0425606378620096
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.010427098000000001	1.0421455625916474
LATHOSTEROLOSIS	0.010006979000000001	1.0001563963240587
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.010006979000000001	1.0001563963240587
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.010006979000000001	1.0001563963240587
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.010006979000000001	1.0001563963240587
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.010006979000000001	1.0001563963240587
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.010006979000000001	1.0001563963240587
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.009990494	0.9985087883703095
ELSAHY-WATERS SYNDROME; ESWS	0.009990494	0.9985087883703095
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.009990494	0.9985087883703095
HOLOPROSENCEPHALY 5; HPE5	0.009990494	0.9985087883703095
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.009990494	0.9985087883703095
JABERI-ELAHI SYNDROME; JABELS	0.009964401	0.995900900330444
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.009964401	0.995900900330444
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.009964401	0.995900900330444
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.009932410000000001	0.9927035314467079
ACITRETIN/ETRETINATE EMBRYOPATHY	0.009932410000000001	0.9927035314467079
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.009906317	0.9900956434068422
KAGAMI-OGATA SYNDROME	0.009906317	0.9900956434068422
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009889832	0.988448035453093
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009889832	0.988448035453093
ADAMS-OLIVER SYNDROME	0.009469713000000001	0.9464588691855047
JACOBSEN SYNDROME	0.009469713000000001	0.9464588691855047
KAGAMI-OGATA SYNDROME	0.009469713000000001	0.9464588691855047
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.009469713000000001	0.9464588691855047
MICROFORM HOLOPROSENCEPHALY	0.009469713000000001	0.9464588691855047
PELIZAEUS-MERZBACHER DISEASE	0.009469713000000001	0.9464588691855047
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009469713000000001	0.9464588691855047
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.009465560000000001	0.9460437939151425
SCHINZEL-GIEDION SYNDROME	0.009465560000000001	0.9460437939151425
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.009465560000000001	0.9460437939151425
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.009465560000000001	0.9460437939151425
DISTAL 17P13.1 MICRODELETION SYNDROME	0.009465560000000001	0.9460437939151425
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009465560000000001	0.9460437939151425
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.009465560000000001	0.9460437939151425
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.009465560000000001	0.9460437939151425
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.009465560000000001	0.9460437939151425
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.009465560000000001	0.9460437939151425
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.009439467	0.943435905875277
PRADER-WILLI SYNDROME; PWS	0.009439467	0.943435905875277
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.009439467	0.943435905875277
PITT-HOPKINS SYNDROME	0.009439467	0.943435905875277
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.009439467	0.943435905875277
PEHO SYNDROME; PEHO	0.009439467	0.943435905875277
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.009439467	0.943435905875277
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.009439467	0.943435905875277
WILLIAMS-BEUREN SYNDROME; WBS	0.009422982	0.9417882979215277
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.009422982	0.9417882979215277
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.009422982	0.9417882979215277
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.009364898	0.9359830409979261
ROIFMAN SYNDROME; RFMN	0.009364898	0.9359830409979261
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009364898	0.9359830409979261
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	0.9359830409979261
NEMALINE MYOPATHY 10	0.009364898	0.9359830409979261
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	0.9359830409979261
YUNIS-VARON SYNDROME	0.009364898	0.9359830409979261
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.009002863	0.8997991316539391
SCHAAF-YANG SYNDROME; SHFYNG	0.009002863	0.8997991316539391
15Q14 MICRODELETION SYNDROME	0.009002863	0.8997991316539391
20Q13.33 MICRODELETION SYNDROME	0.009002863	0.8997991316539391
MENTAL RETARDATION, X-LINKED 98; MRX98	0.009002863	0.8997991316539391
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.009002863	0.8997991316539391
GALLOWAY-MOWAT SYNDROME	0.008944779	0.8939938747303375
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.008944779	0.8939938747303375
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.008944779	0.8939938747303375
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.008944779	0.8939938747303375
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.008944779	0.8939938747303375
GAUCHER DISEASE, PERINATAL LETHAL	0.008944779	0.8939938747303375
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	0.8939938747303375
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.008944779	0.8939938747303375
CONGENITAL TOXOPLASMOSIS	0.008944779	0.8939938747303375
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.008928294	0.8923462667765881
CINCA SYNDROME	0.008928294	0.8923462667765881
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008928294	0.8923462667765881
GMS SYNDROME	0.008928294	0.8923462667765881
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.008898048	0.8893233034663606
OGDEN SYNDROME	0.008898048	0.8893233034663606
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.008898048	0.8893233034663606
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.008898048	0.8893233034663606
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.008898048	0.8893233034663606
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.008898048	0.8893233034663606
PITT-HOPKINS SYNDROME	0.008477929	0.847334137198772
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.008477929	0.847334137198772
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.008477929	0.847334137198772
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.008477929	0.847334137198772
20Q11.2 MICRODUPLICATION SYNDROME	0.008477929	0.847334137198772
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.008477929	0.847334137198772
11Q22.2Q22.3 MICRODELETION SYNDROME	0.008477929	0.847334137198772
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.008477929	0.847334137198772
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.008477929	0.847334137198772
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.008477929	0.847334137198772
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.008461444	0.8456865292450229
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.008461444	0.8456865292450229
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.008461444	0.8456865292450229
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.008461444	0.8456865292450229
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.008461444	0.8456865292450229
PEDIATRIC-ONSET GRAVES DISEASE	0.00840336	0.8398812723214211
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.00840336	0.8398812723214211
HYDROLETHALUS	0.00840336	0.8398812723214211
HEC SYNDROME	0.00840336	0.8398812723214211
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.00840336	0.8398812723214211
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	0.8398812723214211
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	0.8398812723214211
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8398812723214211
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	0.8398812723214211
RENAL TUBULAR DYSGENESIS	0.00840336	0.8398812723214211
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00840336	0.8398812723214211
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	0.8398812723214211
OMPHALOCELE	0.00840336	0.8398812723214211
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00840336	0.8398812723214211
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.00840336	0.8398812723214211
BRONCHOPULMONARY DYSPLASIA	0.00840336	0.8398812723214211
CONGENITAL ANALBUMINEMIA	0.00840336	0.8398812723214211
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00840336	0.8398812723214211
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	0.8398812723214211
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	0.8398812723214211
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	0.8398812723214211
ATELOSTEOGENESIS, TYPE I; AO1	0.00840336	0.8398812723214211
INTERMEDIATE NEMALINE MYOPATHY	0.00840336	0.8398812723214211
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	0.8398812723214211
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00840336	0.8398812723214211
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	0.8398812723214211
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00840336	0.8398812723214211
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	0.8398812723214211
TEMPLE SYNDROME	0.00840336	0.8398812723214211
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.00840336	0.8398812723214211
SCHISIS ASSOCIATION	0.00840336	0.8398812723214211
PEMPHIGOID GESTATIONIS	0.00840336	0.8398812723214211
FATCO SYNDROME	0.00840336	0.8398812723214211
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	0.8398812723214211
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00840336	0.8398812723214211
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	0.8398812723214211
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	0.8398812723214211
RESTRICTIVE DERMOPATHY, LETHAL	0.00840336	0.8398812723214211
DISTAL MONOSOMY 17Q	0.00840336	0.8398812723214211
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	0.8398812723214211
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	0.8398812723214211
RETINOPATHY OF PREMATURITY	0.00840336	0.8398812723214211
EBSTEIN MALFORMATION	0.00840336	0.8398812723214211
VELO-FACIAL-SKELETAL SYNDROME	0.00840336	0.8398812723214211
CLASSICAL EHLERS-DANLOS SYNDROME	0.00840336	0.8398812723214211
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	0.8398812723214211
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	0.8398812723214211
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.00840336	0.8398812723214211
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	0.8398812723214211
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	0.8398812723214211
VACTERL/VATER ASSOCIATION	0.00840336	0.8398812723214211
VASCULAR EHLERS-DANLOS SYNDROME	0.00840336	0.8398812723214211
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.00840336	0.8398812723214211
DIETHYLSTILBESTROL SYNDROME	0.00840336	0.8398812723214211
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	0.8398812723214211
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.00840336	0.8398812723214211
TYSHCHENKO SYNDROME	0.00840336	0.8398812723214211
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	0.8398812723214211
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00793651	0.7932215347898557
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.00793651	0.7932215347898557
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.00793651	0.7932215347898557
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.00793651	0.7932215347898557
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00793651	0.7932215347898557
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.00793651	0.7932215347898557
SECKEL SYNDROME 2; SCKL2	0.00793651	0.7932215347898557
3P25.3 MICRODELETION SYNDROME	0.00793651	0.7932215347898557
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00793651	0.7932215347898557
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.00793651	0.7932215347898557
CHUDLEY-LOWRY-HOAR SYNDROME	0.00793651	0.7932215347898557
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.00793651	0.7932215347898557
LIG4 SYNDROME	0.00793651	0.7932215347898557
PEHO-LIKE SYNDROME; PEHOL	0.00793651	0.7932215347898557
HUNTER-MACDONALD SYNDROME	0.00793651	0.7932215347898557
ALLAN-HERNDON-DUDLEY SYNDROME	0.00793651	0.7932215347898557
CHROMOSOME 1P36 DELETION SYNDROME	0.007621981	0.7617856547725788
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.007621981	0.7617856547725788
ACROCALLOSAL SYNDROME; ACLS	0.007621981	0.7617856547725788
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.007097047	0.7093206603174117
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.007097047	0.7093206603174117
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.007097047	0.7093206603174117
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.007097047	0.7093206603174117
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.007097047	0.7093206603174117
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.007080562	0.7076730523636624
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.007080562	0.7076730523636624
DYSOSTEOSCLEROSIS	0.006660442999999999	0.6656838860960738
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.006660442999999999	0.6656838860960738
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.006660442999999999	0.6656838860960738
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.006660442999999999	0.6656838860960738
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.006660442999999999	0.6656838860960738
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006660442999999999	0.6656838860960738
PMM2-CDG	0.006660442999999999	0.6656838860960738
19P13.13 MICRODELETION SYNDROME	0.006660442999999999	0.6656838860960738
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.006555627999999999	0.6552080579084952
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.006555627999999999	0.6552080579084952
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.006555627999999999	0.6552080579084952
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.006135509	0.6132188916409067
CEREBROOCULONASAL SYNDROME	0.006119024	0.6115712836871574
FETAL TRIMETHADIONE SYNDROME	0.006119024	0.6115712836871574
CEREBROOCULONASAL SYNDROME	0.006119024	0.6115712836871574
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.006092930999999999	0.6089633956472921
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.006092930999999999	0.6089633956472921
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.006092930999999999	0.6089633956472921
ZUNICH NEUROECTODERMAL SYNDROME	0.006092930999999999	0.6089633956472921
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.006092930999999999	0.6089633956472921
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.006092930999999999	0.6089633956472921
LUSCAN-LUMISH SYNDROME; LLS	0.006092930999999999	0.6089633956472921
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.006092930999999999	0.6089633956472921
HELSMOORTEL-VAN DER AA SYNDROME	0.006092930999999999	0.6089633956472921
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.006092930999999999	0.6089633956472921
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.006092930999999999	0.6089633956472921
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.006092930999999999	0.6089633956472921
MICROPHTHALMIA WITH LIMB ANOMALIES	0.0055940899999999995	0.5591062892319902
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.0055940899999999995	0.5591062892319902
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.0055940899999999995	0.5591062892319902
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.0055940899999999995	0.5591062892319902
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.0055940899999999995	0.5591062892319902
DE BARSY SYNDROME	0.0055940899999999995	0.5591062892319902
FRANK-TER HAAR SYNDROME; FTHS	0.0055940899999999995	0.5591062892319902
NASODIGITOACOUSTIC SYNDROME	0.0055940899999999995	0.5591062892319902
OGDEN SYNDROME; OGDNS	0.0055940899999999995	0.5591062892319902
CRANIOMETADIAPHYSEAL DYSPLASIA, WORMIAN BONE TYPE	0.0055940899999999995	0.5591062892319902
HYPER-IGE RECURRENT INFECTION SYNDROME, AUTOSOMAL DOMINANT	0.0055940899999999995	0.5591062892319902
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.005567997	0.556498401192125
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.005567997	0.556498401192125
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.005567997	0.556498401192125
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.005567997	0.556498401192125
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005567997	0.556498401192125
PALLISTER-KILLIAN SYNDROME	0.005567997	0.556498401192125
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.005567997	0.556498401192125
DESANTO-SHINAWI SYNDROME	0.005567997	0.556498401192125
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.005567997	0.556498401192125
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.005567997	0.556498401192125
PETTIGREW SYNDROME	0.005567997	0.556498401192125
SIALURIA	0.005567997	0.556498401192125
MENTAL RETARDATION, X-LINKED 19	0.005551512	0.5548507932383757
JOUBERT SYNDROME 1	0.005551512	0.5548507932383757
COFFIN-SIRIS SYNDROME 7; CSS7	0.005551512	0.5548507932383757
MENTAL RETARDATION, X-LINKED 99	0.005551512	0.5548507932383757
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.005551512	0.5548507932383757
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.005551512	0.5548507932383757
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.005551512	0.5548507932383757
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.005551512	0.5548507932383757
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.005551512	0.5548507932383757
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.005551512	0.5548507932383757
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.005131393	0.5128616269707872
DISTAL MONOSOMY 1Q	0.005131393	0.5128616269707872
20P13 MICRODELETION SYNDROME	0.005131393	0.5128616269707872
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.005131393	0.5128616269707872
FILIPPI SYNDROME	0.005131393	0.5128616269707872
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.005131393	0.5128616269707872
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.005131393	0.5128616269707872
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.005131393	0.5128616269707872
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.005026578	0.5023857987832087
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.005026578	0.5023857987832087
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.005026578	0.5023857987832087
MENTAL RETARDATION, X-LINKED 93	0.005026578	0.5023857987832087
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.005026578	0.5023857987832087
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.005026578	0.5023857987832087
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.005026578	0.5023857987832087
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.005026578	0.5023857987832087
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.005026578	0.5023857987832087
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.005026578	0.5023857987832087
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.005026578	0.5023857987832087
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.005026578	0.5023857987832087
LARSEN-LIKE SYNDROME	0.005026578	0.5023857987832087
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.005026578	0.5023857987832087
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.005026578	0.5023857987832087
PETERS-PLUS SYNDROME; PTRPLS	0.004606459	0.4603966325156201
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004606459	0.4603966325156201
6Q TERMINAL DELETION SYNDROME	0.004606459	0.4603966325156201
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.004606459	0.4603966325156201
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.004606459	0.4603966325156201
GRACILE BONE DYSPLASIA; GCLEB	0.004606459	0.4603966325156201
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004606459	0.4603966325156201
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.004606459	0.4603966325156201
AICA-RIBOSIDURIA	0.004606459	0.4603966325156201
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.004606459	0.4603966325156201
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004606459	0.4603966325156201
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.004606459	0.4603966325156201
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.004606459	0.4603966325156201
8P INVERTED DUPLICATION/DELETION SYNDROME	0.004606459	0.4603966325156201
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004606459	0.4603966325156201
FUCOSIDOSIS	0.004606459	0.4603966325156201
WEBB-DATTANI SYNDROME; WEDAS	0.004606459	0.4603966325156201
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.004606459	0.4603966325156201
NOONAN SYNDROME 5; NS5	0.004589974	0.45874902456187083
OPITZ G/BBB SYNDROME	0.004589974	0.45874902456187083
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.004589974	0.45874902456187083
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.004589974	0.45874902456187083
PELGER-HUET ANOMALY; PHA	0.004589974	0.45874902456187083
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.004589974	0.45874902456187083
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.004589974	0.45874902456187083
DESMOSTEROLOSIS	0.004589974	0.45874902456187083
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.45874902456187083
PETERS PLUS SYNDROME	0.004589974	0.45874902456187083
RAMOS-ARROYO SYNDROME	0.004589974	0.45874902456187083
ZECHI-CEIDE SYNDROME	0.004589974	0.45874902456187083
FAMILIAL LAMBDOID SYNOSTOSIS	0.004589974	0.45874902456187083
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.004589974	0.45874902456187083
LARSEN SYNDROME	0.004589974	0.45874902456187083
MARSHALL-SMITH SYNDROME	0.004589974	0.45874902456187083
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.004589974	0.45874902456187083
NEUROFACIODIGITORENAL SYNDROME	0.004589974	0.45874902456187083
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.004589974	0.45874902456187083
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.004589974	0.45874902456187083
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.004589974	0.45874902456187083
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.004589974	0.45874902456187083
KEIPERT SYNDROME; KPTS	0.004589974	0.45874902456187083
CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-POLYDACTYLY SYNDROME	0.004589974	0.45874902456187083
ZECHI-CEIDE SYNDROME	0.004589974	0.45874902456187083
49,XXXYY SYNDROME	0.004589974	0.45874902456187083
METAPHYSEAL ACROSCYPHODYSPLASIA	0.004589974	0.45874902456187083
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.004589974	0.45874902456187083
ODONTOCHONDRODYSPLASIA; ODCD	0.00406504	0.40628403010670366
CARTILAGE-HAIR HYPOPLASIA	0.00406504	0.40628403010670366
CUTIS LAXA	0.00406504	0.40628403010670366
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00406504	0.40628403010670366
W SYNDROME	0.00406504	0.40628403010670366
FG SYNDROME 2; FGS2	0.00406504	0.40628403010670366
AUTOSOMAL DOMINANT HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00406504	0.40628403010670366
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00406504	0.40628403010670366
SPONDYLOEPIPHYSEAL DYSPLASIA, KONDO-FU TYPE; SEDKF	0.00406504	0.40628403010670366
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.00406504	0.40628403010670366
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00406504	0.40628403010670366
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.00406504	0.40628403010670366
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00406504	0.40628403010670366
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00406504	0.40628403010670366
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.00406504	0.40628403010670366
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.00406504	0.40628403010670366
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.00406504	0.40628403010670366
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.00406504	0.40628403010670366
ACROMESOMELIC DYSPLASIA, MAROTEAUX TYPE	0.00406504	0.40628403010670366
HYPERTELORISM, TEEBI TYPE; TBHS	0.00406504	0.40628403010670366
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00406504	0.40628403010670366
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00406504	0.40628403010670366
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00406504	0.40628403010670366
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.00406504	0.40628403010670366
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.00406504	0.40628403010670366
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00406504	0.40628403010670366
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.00406504	0.40628403010670366
268650 RUDIGER SYNDROME	0.00406504	0.40628403010670366
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00406504	0.40628403010670366
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.00406504	0.40628403010670366
SHORT SYNDROME	0.00406504	0.40628403010670366
CRANIOSYNOSTOSIS 4; CRS4	0.00406504	0.40628403010670366
HYPERTELORISM, TEEBI TYPE	0.00406504	0.40628403010670366
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.00406504	0.40628403010670366
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00406504	0.40628403010670366
SHORT SYNDROME	0.00406504	0.40628403010670366
STEEL SYNDROME; STLS	0.00406504	0.40628403010670366
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.00406504	0.40628403010670366
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.00406504	0.40628403010670366
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00406504	0.40628403010670366
SAUL-WILSON SYNDROME; SWILS	0.00406504	0.40628403010670366
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.00406504	0.40628403010670366
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.00406504	0.40628403010670366
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.00406504	0.40628403010670366
AXENFELD-RIEGER SYNDROME	0.00406504	0.40628403010670366
GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME; GIDID	0.00406504	0.40628403010670366
TRICHOHEPATOENTERIC SYNDROME 2	0.00406504	0.40628403010670366
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.00406504	0.40628403010670366
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00406504	0.40628403010670366
SYNDROMIC DIARRHEA	0.00406504	0.40628403010670366
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00406504	0.40628403010670366
TRICHOHEPATOENTERIC SYNDROME 1	0.00406504	0.40628403010670366
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00406504	0.40628403010670366
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.00406504	0.40628403010670366
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00406504	0.40628403010670366
PLATYSPONDYLIC DYSPLASIA, TORRANCE TYPE	0.00406504	0.40628403010670366
TETRASOMY 12P	0.00406504	0.40628403010670366
MENTAL RETARDATION, X-LINKED 90	0.003556941	0.35550162466587504
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.003556941	0.35550162466587504
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0035569409999999997	0.355501624665875
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.0035569409999999997	0.355501624665875
MEND SYNDROME	0.0035569409999999997	0.355501624665875
KOOLEN-DE VRIES SYNDROME; KDVS	0.0035569409999999997	0.355501624665875
CK SYNDROME	0.0035569409999999997	0.355501624665875
OROFACIODIGITAL SYNDROME TYPE 6	0.0035569409999999997	0.355501624665875
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.0035569409999999997	0.355501624665875
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0035569409999999997	0.355501624665875
WIEDEMANN-STEINER SYNDROME; WDSTS	0.0035569409999999997	0.355501624665875
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0035569409999999997	0.355501624665875
EMANUEL SYNDROME	0.0035569409999999997	0.355501624665875
KABUKI SYNDROME 1	0.0035569409999999997	0.355501624665875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.0035569409999999997	0.355501624665875
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.0035569409999999997	0.355501624665875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.0035569409999999997	0.355501624665875
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.0035569409999999997	0.355501624665875
COFFIN-LOWRY SYNDROME; CLS	0.0035569409999999997	0.355501624665875
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0035569409999999997	0.355501624665875
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0035569409999999997	0.355501624665875
MARDEN-WALKER SYNDROME	0.0035569409999999997	0.355501624665875
ZTTK SYNDROME; ZTTKS	0.0035569409999999997	0.355501624665875
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.0035569409999999997	0.355501624665875
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.0035569409999999997	0.355501624665875
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0035569409999999997	0.355501624665875
WITTEVEEN-KOLK SYNDROME	0.0035569409999999997	0.355501624665875
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.0035569409999999997	0.355501624665875
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.0035569409999999997	0.355501624665875
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.0035569409999999997	0.355501624665875
MEND SYNDROME; MEND	0.0035569409999999997	0.355501624665875
POTOCKI-LUPSKI SYNDROME	0.003032007	0.303036630210708
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.003032007	0.303036630210708
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.003032007	0.303036630210708
DUPLICATION/INVERSION 15Q11	0.003032007	0.303036630210708
LISSENCEPHALY, X-LINKED, 2	0.003032007	0.303036630210708
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.003032007	0.303036630210708
7Q11.23 MICRODUPLICATION SYNDROME	0.003032007	0.303036630210708
C SYNDROME	0.003032007	0.303036630210708
ZIMMERMANN-LABAND SYNDROME 1	0.003032007	0.303036630210708
TETRASOMY 9P	0.003032007	0.303036630210708
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.003032007	0.303036630210708
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.003032007	0.303036630210708
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.003032007	0.303036630210708
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.003032007	0.303036630210708
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.003032007	0.303036630210708
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.003032007	0.303036630210708
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.003032007	0.303036630210708
WIEACKER-WOLFF SYNDROME	0.003032007	0.303036630210708
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.003032007	0.303036630210708
TEMPLE-BARAITSER SYNDROME	0.003032007	0.303036630210708
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.0030320069999999998	0.3030366302107079
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0030320069999999998	0.3030366302107079
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0030320069999999998	0.3030366302107079
AU-KLINE SYNDROME; AUKS	0.003015522	0.3013890222569587
WHITE-SUTTON SYNDROME; WHSUS	0.003015522	0.3013890222569587
DUBOWITZ SYNDROME	0.003015522	0.3013890222569587
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.003015522	0.3013890222569587
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.003015522	0.3013890222569587
IMMUNODEFICIENCY 23; IMD23	0.003015522	0.3013890222569587
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.003015522	0.3013890222569587
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.003015522	0.3013890222569587
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.003015522	0.3013890222569587
OROFACIODIGITAL SYNDROME VI	0.003015522	0.3013890222569587
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.003015522	0.3013890222569587
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.003015522	0.3013890222569587
HADZISELIMOVIC SYNDROME	0.003015522	0.3013890222569587
JOUBERT SYNDROME 2	0.003015522	0.3013890222569587
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.003015522	0.3013890222569587
WARSAW BREAKAGE SYNDROME; WABS	0.003015522	0.3013890222569587
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.003015522	0.3013890222569587
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.003015522	0.3013890222569587
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.003015522	0.3013890222569587
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.003015522	0.3013890222569587
ARTERIAL TORTUOSITY SYNDROME	0.003015522	0.3013890222569587
RING CHROMOSOME 14 SYNDROME	0.0030155219999999996	0.3013890222569586
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.0030155219999999996	0.3013890222569586
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.0030155219999999996	0.3013890222569586
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0030155219999999996	0.3013890222569586
OROFACIODIGITAL SYNDROME I; OFD1	0.0025954029999999996	0.25939985598937004
CORNELIA DE LANGE SYNDROME 3	0.0025954029999999996	0.25939985598937004
15Q24 MICRODELETION SYNDROME	0.0025954029999999996	0.25939985598937004
ALEXANDER DISEASE	0.0025954029999999996	0.25939985598937004
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.0025954029999999996	0.25939985598937004
RENPENNING SYNDROME 1; RENS1	0.0025954029999999996	0.25939985598937004
PFEIFFER SYNDROME TYPE 3	0.0025954029999999996	0.25939985598937004
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.0025954029999999996	0.25939985598937004
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.0025954029999999996	0.25939985598937004
CORNELIA DE LANGE SYNDROME 1	0.0025954029999999996	0.25939985598937004
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.0025954029999999996	0.25939985598937004
PFEIFFER SYNDROME TYPE 2	0.0025954029999999996	0.25939985598937004
CONGENITAL MYASTHENIC SYNDROME	0.0025954029999999996	0.25939985598937004
CHROMOSOME 16P13.3 DELETION SYNDROME	0.0025954029999999996	0.25939985598937004
WIEDEMANN-STEINER SYNDROME	0.0025954029999999996	0.25939985598937004
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.0025954029999999996	0.25939985598937004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.0025954029999999996	0.25939985598937004
3Q29 MICRODUPLICATION SYNDROME	0.0025954029999999996	0.25939985598937004
ZIMMERMANN-LABAND SYNDROME	0.0025954029999999996	0.25939985598937004
MOSAIC TRISOMY 14	0.0025954029999999996	0.25939985598937004
RUBINSTEIN-TAYBI SYNDROME	0.0025954029999999996	0.25939985598937004
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.0025954029999999996	0.25939985598937004
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0025954029999999996	0.25939985598937004
HENNEKAM-BEEMER SYNDROME	0.0025954029999999996	0.25939985598937004
HARROD SYNDROME	0.0025954029999999996	0.25939985598937004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.0025954029999999996	0.25939985598937004
2Q33.1 DELETION SYNDROME	0.0025954029999999996	0.25939985598937004
FRYNS SYNDROME	0.0025954029999999996	0.25939985598937004
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0025954029999999996	0.25939985598937004
MATERNAL PHENYLKETONURIA	0.0025954029999999996	0.25939985598937004
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.0025954029999999996	0.25939985598937004
COWDEN SYNDROME	0.0025954029999999996	0.25939985598937004
COFFIN-LOWRY SYNDROME	0.0025954029999999996	0.25939985598937004
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.0025954029999999996	0.25939985598937004
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0025954029999999996	0.25939985598937004
MENTAL RETARDATION, X-LINKED 104; MRX104	0.0025954029999999996	0.25939985598937004
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.0025954029999999996	0.25939985598937004
GLASS SYNDROME	0.0025954029999999996	0.25939985598937004
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0025954029999999996	0.25939985598937004
DUBOWITZ SYNDROME	0.0025954029999999996	0.25939985598937004
8P11.2 DELETION SYNDROME	0.0025954029999999996	0.25939985598937004
1Q21.1 MICRODELETION SYNDROME	0.0025954029999999996	0.25939985598937004
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.0025954029999999996	0.25939985598937004
MONOSOMY 9P	0.0025954029999999996	0.25939985598937004
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.0025954029999999996	0.25939985598937004
MOMO SYNDROME	0.0025954029999999996	0.25939985598937004
CHROMOSOME 1P35 DELETION SYNDROME	0.0025954029999999996	0.25939985598937004
SECKEL SYNDROME 1; SCKL1	0.0025954029999999996	0.25939985598937004
OROFACIODIGITAL SYNDROME TYPE 1	0.0025954029999999996	0.25939985598937004
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.0025954029999999996	0.25939985598937004
COFFIN-SIRIS SYNDROME 1; CSS1	0.0025954029999999996	0.25939985598937004
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.0025954029999999996	0.25939985598937004
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0025954029999999996	0.25939985598937004
MUENKE SYNDROME	0.0025954029999999996	0.25939985598937004
COWDEN SYNDROME 5; CWS5	0.0025954029999999996	0.25939985598937004
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.0025954029999999996	0.25939985598937004
C SYNDROME	0.0025954029999999996	0.25939985598937004
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.0025954029999999996	0.25939985598937004
VICI SYNDROME	0.0025954029999999996	0.25939985598937004
CLASSIC HOMOCYSTINURIA	0.0025954029999999996	0.25939985598937004
COWDEN SYNDROME 6; CWS6	0.0025954029999999996	0.25939985598937004
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.002490588	0.24892402780179163
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.002490588	0.24892402780179163
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.002490588	0.24892402780179163
COG1-CDG	0.002490588	0.24892402780179163
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.002490588	0.24892402780179163
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.002490588	0.24892402780179163
LEGIUS SYNDROME	0.002490588	0.24892402780179163
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.002490588	0.24892402780179163
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.002490588	0.24892402780179163
CAP MYOPATHY	0.002490588	0.24892402780179163
ADDUCTED THUMBS SYNDROME	0.002490588	0.24892402780179163
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.002490588	0.24892402780179163
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.002490588	0.24892402780179163
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.002490588	0.24892402780179163
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.002490588	0.24892402780179163
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.002490588	0.24892402780179163
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002490588	0.24892402780179163
RIGID SPINE MUSCULAR DYSTROPHY 1	0.002490588	0.24892402780179163
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.002490588	0.24892402780179163
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.002490588	0.24892402780179163
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.002490588	0.24892402780179163
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.002490588	0.24892402780179163
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002490588	0.24892402780179163
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.002490588	0.24892402780179163
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.002490588	0.24892402780179163
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.002490588	0.24892402780179163
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.002490588	0.24892402780179163
NEMALINE MYOPATHY 7; NEM7	0.002490588	0.24892402780179163
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.002490588	0.24892402780179163
LATERAL MENINGOCELE SYNDROME	0.002490588	0.24892402780179163
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002490588	0.24892402780179163
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.002490588	0.24892402780179163
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.002490588	0.24892402780179163
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.002490588	0.24892402780179163
MYOPATHY, CENTRONUCLEAR, 5	0.002490588	0.24892402780179163
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.002490588	0.24892402780179163
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.002490588	0.24892402780179163
MÃœLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.002490588	0.24892402780179163
NEMALINE MYOPATHY 4	0.002490588	0.24892402780179163
FUMARASE DEFICIENCY; FMRD	0.002490588	0.24892402780179163
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.002490588	0.24892402780179163
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.002490588	0.24892402780179163
RING CHROMOSOME 13 SYNDROME	0.002490588	0.24892402780179163
CLASSIC MULTIMINICORE MYOPATHY	0.002490588	0.24892402780179163
CHROMOSOME 16Q22 DELETION SYNDROME	0.002490588	0.24892402780179163
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.002490588	0.24892402780179163
TARP SYNDROME; TARPS	0.002490588	0.24892402780179163
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.002070469	0.20693486153420304
PGM3-CDG	0.002070469	0.20693486153420304
DISTAL TRISOMY 17Q	0.002070469	0.20693486153420304
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.002070469	0.20693486153420304
16Q24.3 MICRODELETION SYNDROME	0.002070469	0.20693486153420304
6Q25 MICRODELETION SYNDROME	0.002070469	0.20693486153420304
HYPEREKPLEXIA 4; HKPX4	0.002070469	0.20693486153420304
MONOSOMY 18Q	0.002070469	0.20693486153420304
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.002070469	0.20693486153420304
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.002070469	0.20693486153420304
DISTAL MONOSOMY 3P	0.002070469	0.20693486153420304
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.002070469	0.20693486153420304
MENTAL RETARDATION, X-LINKED 91; MRX91	0.002070469	0.20693486153420304
COG5-CDG	0.002070469	0.20693486153420304
8P23.1 MICRODELETION SYNDROME	0.002070469	0.20693486153420304
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.002070469	0.20693486153420304
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.002070469	0.20693486153420304
KEPPEN-LUBINSKY SYNDROME	0.002070469	0.20693486153420304
MICRO SYNDROME	0.002070469	0.20693486153420304
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002070469	0.20693486153420304
KABUKI SYNDROME	0.002070469	0.20693486153420304
CATEL-MANZKE SYNDROME; CATMANS	0.002070469	0.20693486153420304
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.002070469	0.20693486153420304
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.002070469	0.20693486153420304
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.002070469	0.20693486153420304
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.002070469	0.20693486153420304
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.002070469	0.20693486153420304
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.002070469	0.20693486153420304
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.002070469	0.20693486153420304
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.002070469	0.20693486153420304
TETRASOMY 5P	0.002070469	0.20693486153420304
CRISPONI SYNDROME	0.002070469	0.20693486153420304
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.002070469	0.20693486153420304
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.002070469	0.20693486153420304
XP22.13P22.2 DUPLICATION SYNDROME	0.002070469	0.20693486153420304
PERRAULT SYNDROME 5; PRLTS5	0.002070469	0.20693486153420304
MOWAT-WILSON SYNDROME	0.002070469	0.20693486153420304
PYRUVATE DEHYDROGENASE DEFICIENCY	0.002070469	0.20693486153420304
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.002070469	0.20693486153420304
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.002070469	0.20693486153420304
FETAL GAUCHER DISEASE	0.002070469	0.20693486153420304
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.002070469	0.20693486153420304
DIGEORGE SYNDROME; DGS	0.002070469	0.20693486153420304
LIPOID PROTEINOSIS	0.002070469	0.20693486153420304
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.002070469	0.20693486153420304
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002070469	0.20693486153420304
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.002070469	0.20693486153420304
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.002053984	0.20528725358045374
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.002053984	0.20528725358045374
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.002053984	0.20528725358045374
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.002053984	0.20528725358045374
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.002053984	0.20528725358045374
PSEUDOAMINOPTERIN SYNDROME	0.002053984	0.20528725358045374
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.002053984	0.20528725358045374
CRANIOFRONTONASAL DYSPLASIA	0.002053984	0.20528725358045374
MCKUSICK-KAUFMAN SYNDROME	0.002053984	0.20528725358045374
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.002053984	0.20528725358045374
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA AND PALMOPLANTAR HYPERKERATOSIS	0.002053984	0.20528725358045374
MONOSOMY 22	0.002053984	0.20528725358045374
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.002053984	0.20528725358045374
FEINGOLD SYNDROME 1; FGLDS1	0.002053984	0.20528725358045374
MENTAL RETARDATION, BUENOS AIRES TYPE	0.002053984	0.20528725358045374
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.002053984	0.20528725358045374
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.002053984	0.20528725358045374
FRONTOMETAPHYSEAL DYSPLASIA	0.002053984	0.20528725358045374
CRI-DU-CHAT SYNDROME	0.002053984	0.20528725358045374
15Q26 OVERGROWTH SYNDROME	0.002053984	0.20528725358045374
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.002053984	0.20528725358045374
601095 HARROD SYNDROME	0.002053984	0.20528725358045374
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.002053984	0.20528725358045374
RABSON-MENDENHALL SYNDROME	0.002053984	0.20528725358045374
CAREY-FINEMAN-ZITER SYNDROME	0.002053984	0.20528725358045374
OTOFACIOCERVICAL SYNDROME	0.002053984	0.20528725358045374
CHROMOSOME 17Q12 DELETION SYNDROME	0.002053984	0.20528725358045374
MEIER-GORLIN SYNDROME 1; MGORS1	0.002053984	0.20528725358045374
POLYVALVULAR HEART DISEASE SYNDROME	0.002053984	0.20528725358045374
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.002053984	0.20528725358045374
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.002053984	0.20528725358045374
CHROMOSOME 18P DELETION SYNDROME	0.002053984	0.20528725358045374
ROBERTS SYNDROME; RBS	0.002053984	0.20528725358045374
FRASER SYNDROME	0.002053984	0.20528725358045374
ALAZAMI-YUAN SYNDROME	0.002053984	0.20528725358045374
3Q29 MICRODELETION SYNDROME	0.002053984	0.20528725358045374
MENTAL RETARDATION, X-LINKED 2	0.002053984	0.20528725358045374
17Q21.31 MICRODUPLICATION SYNDROME	0.002053984	0.20528725358045374
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.002053984	0.20528725358045374
SECKEL SYNDROME 5; SCKL5	0.002053984	0.20528725358045374
8Q21.11 MICRODELETION SYNDROME	0.002053984	0.20528725358045374
BARDET-BIEDL SYNDROME 1; BBS1	0.002053984	0.20528725358045374
SCHWARTZ-JAMPEL SYNDROME	0.002053984	0.20528725358045374
DELAYED SPEECH-FACIAL ASYMMETRY-STRABISMUS-EAR LOBE CREASES SYNDROME	0.002053984	0.20528725358045374
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.002053984	0.20528725358045374
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.002053984	0.20528725358045374
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.002053984	0.20528725358045374
TRISOMY 17P	0.002053984	0.20528725358045374
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.002053984	0.20528725358045374
MENTAL RETARDATION, X-LINKED 45	0.002053984	0.20528725358045374
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002053984	0.20528725358045374
FANCONI ANEMIA	0.002053984	0.20528725358045374
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.002053984	0.20528725358045374
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.002053984	0.20528725358045374
KENNERKNECHT SYNDROME	0.002053984	0.20528725358045374
HALLERMANN-STREIFF SYNDROME; HSS	0.002053984	0.20528725358045374
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.002053984	0.20528725358045374
MOSAIC TRISOMY 9	0.002053984	0.20528725358045374
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.002053984	0.20528725358045374
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.002053984	0.20528725358045374
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.002053984	0.20528725358045374
GERMAN SYNDROME	0.002053984	0.20528725358045374
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.002053984	0.20528725358045374
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.002053984	0.20528725358045374
TURNPENNY-FRY SYNDROME; TPFS	0.002053984	0.20528725358045374
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.002027891	0.20267936554058838
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.002027891	0.20267936554058838
KETOADIPICACIDURIA	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.002027891	0.20267936554058838
ADENYLOSUCCINATE LYASE DEFICIENCY	0.002027891	0.20267936554058838
CHROMOSOME 16P13.2 DELETION SYNDROME	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.002027891	0.20267936554058838
CYCLIC VOMITING SYNDROME	0.002027891	0.20267936554058838
RECOMBINANT CHROMOSOME 8 SYNDROME	0.002027891	0.20267936554058838
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.002027891	0.20267936554058838
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002027891	0.20267936554058838
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.002027891	0.20267936554058838
CODAS SYNDROME	0.002027891	0.20267936554058838
TENORIO SYNDROME; TNORS	0.002027891	0.20267936554058838
GLYCINE ENCEPHALOPATHY; GCE	0.002027891	0.20267936554058838
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.002027891	0.20267936554058838
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.002027891	0.20267936554058838
ASPARTYLGLUCOSAMINURIA; AGU	0.002027891	0.20267936554058838
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.002027891	0.20267936554058838
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.002027891	0.20267936554058838
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.002027891	0.20267936554058838
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002027891	0.20267936554058838
NIEMANN-PICK DISEASE, TYPE C2	0.002027891	0.20267936554058838
CHROMOSOME 5Q12 DELETION SYNDROME	0.002027891	0.20267936554058838
JOUBERT SYNDROME 30; JBTS30	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.002027891	0.20267936554058838
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.002027891	0.20267936554058838
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.002027891	0.20267936554058838
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.002027891	0.20267936554058838
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.002027891	0.20267936554058838
PYRUVATE CARBOXYLASE DEFICIENCY	0.002027891	0.20267936554058838
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.002027891	0.20267936554058838
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.002027891	0.20267936554058838
NEURAMINIDASE DEFICIENCY	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.002027891	0.20267936554058838
AL KAISSI SYNDROME; ALKAS	0.002027891	0.20267936554058838
ELEJALDE DISEASE	0.002027891	0.20267936554058838
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.002027891	0.20267936554058838
COHEN SYNDROME	0.002027891	0.20267936554058838
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002027891	0.20267936554058838
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.002027891	0.20267936554058838
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.002027891	0.20267936554058838
PONTINE TEGMENTAL CAP DYSPLASIA	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.002027891	0.20267936554058838
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.002027891	0.20267936554058838
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.002027891	0.20267936554058838
TIMOTHY SYNDROME; TS	0.002027891	0.20267936554058838
COFFIN-SIRIS SYNDROME 4; CSS4	0.002027891	0.20267936554058838
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.002027891	0.20267936554058838
COFFIN-SIRIS SYNDROME 2; CSS2	0.002027891	0.20267936554058838
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.002027891	0.20267936554058838
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.002027891	0.20267936554058838
CHROMOSOME 10Q26 DELETION SYNDROME	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002027891	0.20267936554058838
FOLATE MALABSORPTION, HEREDITARY	0.002027891	0.20267936554058838
COFFIN-SIRIS SYNDROME 3; CSS3	0.002027891	0.20267936554058838
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.002027891	0.20267936554058838
HOLOPROSENCEPHALY 1; HPE1	0.002027891	0.20267936554058838
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.002027891	0.20267936554058838
SALLA DISEASE	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.002027891	0.20267936554058838
LEIGH SYNDROME; LS	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.002027891	0.20267936554058838
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.002027891	0.20267936554058838
CHROMOSOME 18Q DELETION SYNDROME	0.002027891	0.20267936554058838
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.002027891	0.20267936554058838
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002027891	0.20267936554058838
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.002027891	0.20267936554058838
MICROPHTHALMIA, SYNDROMIC 1	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.002027891	0.20267936554058838
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.002027891	0.20267936554058838
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.002027891	0.20267936554058838
OHDO SYNDROME	0.002027891	0.20267936554058838
MENTAL RETARDATION, X-LINKED 102	0.002027891	0.20267936554058838
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002027891	0.20267936554058838
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.002027891	0.20267936554058838
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.002027891	0.20267936554058838
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.002027891	0.20267936554058838
XQ25 DUPLICATION SYNDROME	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002027891	0.20267936554058838
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.002027891	0.20267936554058838
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.002027891	0.20267936554058838
LISSENCEPHALY 5; LIS5	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.002027891	0.20267936554058838
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.002027891	0.20267936554058838
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.002027891	0.20267936554058838
HYPERPROLINEMIA, TYPE I	0.002027891	0.20267936554058838
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.002027891	0.20267936554058838
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.002027891	0.20267936554058838
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.002027891	0.20267936554058838
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002027891	0.20267936554058838
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.002027891	0.20267936554058838
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.002027891	0.20267936554058838
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.002027891	0.20267936554058838
ETHYLMALONIC ENCEPHALOPATHY	0.002027891	0.20267936554058838
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.002027891	0.20267936554058838
SHASHI-PENA SYNDROME; SHAPNS	0.002027891	0.20267936554058838
GRISCELLI SYNDROME TYPE 1	0.002027891	0.20267936554058838
SMITH-KINGSMORE SYNDROME; SKS	0.002027891	0.20267936554058838
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.002027891	0.20267936554058838
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.002027891	0.20267936554058838
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.002027891	0.20267936554058838
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.002027891	0.20267936554058838
GRISCELLI SYNDROME, TYPE 1	0.002027891	0.20267936554058838
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.002027891	0.20267936554058838
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.002027891	0.20267936554058838
METACHROMATIC LEUKODYSTROPHY	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.002027891	0.20267936554058838
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002027891	0.20267936554058838
IMMUNODEFICIENCY 49; IMD49	0.002027891	0.20267936554058838
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.002027891	0.20267936554058838
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.002027891	0.20267936554058838
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002027891	0.20267936554058838
MEHMO SYNDROME; MEHMO	0.002027891	0.20267936554058838
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.002027891	0.20267936554058838
KLEEFSTRA SYNDROME 2; KLEFS2	0.002027891	0.20267936554058838
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.002027891	0.20267936554058838
SSR4-CDG	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.002027891	0.20267936554058838
MENTAL RETARDATION, X-LINKED 1	0.002027891	0.20267936554058838
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.002027891	0.20267936554058838
HOLOPROSENCEPHALY 2; HPE2	0.002027891	0.20267936554058838
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.002027891	0.20267936554058838
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.002027891	0.20267936554058838
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.002027891	0.20267936554058838
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002027891	0.20267936554058838
STT3B-CDG	0.002027891	0.20267936554058838
STT3A-CDG	0.002027891	0.20267936554058838
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002027891	0.20267936554058838
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002027891	0.20267936554058838
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.002027891	0.20267936554058838
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.002027891	0.20267936554058838
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.002027891	0.20267936554058838
SMITH-MAGENIS SYNDROME; SMS	0.002027891	0.20267936554058838
AICARDI-GOUTIERES SYNDROME 7	0.002027891	0.20267936554058838
PELIZAEUS-MERZBACHER DISEASE	0.002027891	0.20267936554058838
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.002027891	0.20267936554058838
MENKES DISEASE	0.002027891	0.20267936554058838
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.002027891	0.20267936554058838
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.002027891	0.20267936554058838
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.002027891	0.20267936554058838
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.002027891	0.20267936554058838
ADAMS-OLIVER SYNDROME 1; AOS1	0.002027891	0.20267936554058838
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.002027891	0.20267936554058838
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.002027891	0.20267936554058838
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.002027891	0.20267936554058838
WEAVER SYNDROME	0.002027891	0.20267936554058838
ADENYLOSUCCINASE DEFICIENCY	0.002027891	0.20267936554058838
BARAITSER-WINTER SYNDROME 1; BRWS1	0.002027891	0.20267936554058838
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.002027891	0.20267936554058838
TARP SYNDROME	0.002027891	0.20267936554058838
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002027891	0.20267936554058838
MAPLE SYRUP URINE DISEASE; MSUD	0.002027891	0.20267936554058838
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002027891	0.20267936554058838
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.002027891	0.20267936554058838
DISTAL NEBULIN MYOPATHY	0.00152905	0.15282225912528663
HYPERTROPHIC OSTEOARTHROPATHY, PRIMARY, AUTOSOMAL RECESSIVE, 1; PHOAR1	0.00152905	0.15282225912528663
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.00152905	0.15282225912528663
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.00152905	0.15282225912528663
SHELDON-HALL SYNDROME	0.00152905	0.15282225912528663
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.00152905	0.15282225912528663
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.00152905	0.15282225912528663
OROFACIODIGITAL SYNDROME TYPE 2	0.00152905	0.15282225912528663
ARRHINIA-CHOANAL ATRESIA-MICROPHTHALMIA SYNDROME	0.00152905	0.15282225912528663
608028 THAI SYMPHALANGISM SYNDROME	0.00152905	0.15282225912528663
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00152905	0.15282225912528663
MOEBIUS SYNDROME; MBS	0.00152905	0.15282225912528663
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00152905	0.15282225912528663
MEIER-GORLIN SYNDROME 7	0.00152905	0.15282225912528663
OLIVER SYNDROME	0.00152905	0.15282225912528663
MYOPATHY, DISTAL, 1; MPD1	0.00152905	0.15282225912528663
OROFACIODIGITAL SYNDROME IX; OFD9	0.00152905	0.15282225912528663
OROFACIODIGITAL SYNDROME IV; OFD4	0.00152905	0.15282225912528663
NEMALINE MYOPATHY 3; NEM3	0.00152905	0.15282225912528663
MONOSOMY 5P	0.00152905	0.15282225912528663
MUSCULAR DYSTROPHY, CONGENITAL, DAVIGNON-CHAUVEAU TYPE; MDCDC	0.00152905	0.15282225912528663
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.00152905	0.15282225912528663
HAMAMY SYNDROME; HMMS	0.00152905	0.15282225912528663
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.00152905	0.15282225912528663
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00152905	0.15282225912528663
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00152905	0.15282225912528663
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.00152905	0.15282225912528663
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00152905	0.15282225912528663
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00152905	0.15282225912528663
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00152905	0.15282225912528663
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.00152905	0.15282225912528663
HYPER-IGE RECURRENT INFECTION SYNDROME 3, AUTOSOMAL RECESSIVE; HIES3	0.00152905	0.15282225912528663
WRINKLY SKIN SYNDROME	0.00152905	0.15282225912528663
9P13 MICRODELETION SYNDROME	0.00152905	0.15282225912528663
SHORT STATURE-VALVULAR HEART DISEASE-CHARACTERISTIC FACIES SYNDROME	0.00152905	0.15282225912528663
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.00152905	0.15282225912528663
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.00152905	0.15282225912528663
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.00152905	0.15282225912528663
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00152905	0.15282225912528663
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.00152905	0.15282225912528663
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00152905	0.15282225912528663
HYPOGLOSSIA WITH SITUS INVERSUS	0.00152905	0.15282225912528663
MACS SYNDROME	0.00152905	0.15282225912528663
THREE M SYNDROME 2; 3M2	0.00152905	0.15282225912528663
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00152905	0.15282225912528663
PSEUDOXANTHOMA ELASTICUM	0.00152905	0.15282225912528663
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.00152905	0.15282225912528663
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.00152905	0.15282225912528663
LOEYS-DIETZ SYNDROME 3; LDS3	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00152905	0.15282225912528663
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00152905	0.15282225912528663
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00152905	0.15282225912528663
NEMALINE MYOPATHY 2; NEM2	0.00152905	0.15282225912528663
NEMALINE MYOPATHY 1; NEM1	0.00152905	0.15282225912528663
PFEIFFER SYNDROME	0.00152905	0.15282225912528663
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00152905	0.15282225912528663
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00152905	0.15282225912528663
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00152905	0.15282225912528663
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00152905	0.15282225912528663
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00152905	0.15282225912528663
NOONAN SYNDROME 3; NS3	0.00152905	0.15282225912528663
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00152905	0.15282225912528663
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.00152905	0.15282225912528663
PFEIFFER SYNDROME TYPE 1	0.00152905	0.15282225912528663
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00152905	0.15282225912528663
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.00152905	0.15282225912528663
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.00152905	0.15282225912528663
GORDON SYNDROME	0.00152905	0.15282225912528663
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00152905	0.15282225912528663
DOORS SYNDROME	0.00152905	0.15282225912528663
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00152905	0.15282225912528663
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00152905	0.15282225912528663
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.00152905	0.15282225912528663
OCULOCUTANEOUS ALBINISM TYPE 5	0.00152905	0.15282225912528663
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00152905	0.15282225912528663
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00152905	0.15282225912528663
ACRORENAL-MANDIBULAR SYNDROME	0.00152905	0.15282225912528663
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00152905	0.15282225912528663
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00152905	0.15282225912528663
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.00152905	0.15282225912528663
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00152905	0.15282225912528663
NEMALINE MYOPATHY 11, AUTOSOMAL RECESSIVE; NEM11	0.00152905	0.15282225912528663
POSTSYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.00152905	0.15282225912528663
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00152905	0.15282225912528663
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.00152905	0.15282225912528663
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.00152905	0.15282225912528663
MANDIBULOACRAL DYSPLASIA	0.00152905	0.15282225912528663
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.00152905	0.15282225912528663
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.00152905	0.15282225912528663
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.00152905	0.15282225912528663
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00152905	0.15282225912528663
FRIED SYNDROME	0.00152905	0.15282225912528663
HYPOGONADISM-MITRAL VALVE PROLAPSE-INTELLECTUAL DISABILITY SYNDROME	0.00152905	0.15282225912528663
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.00152905	0.15282225912528663
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.00152905	0.15282225912528663
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 8; CMS8	0.00152905	0.15282225912528663
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.00152905	0.15282225912528663
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.00152905	0.15282225912528663
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00152905	0.15282225912528663
CRANIOECTODERMAL DYSPLASIA 1	0.00152905	0.15282225912528663
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.00152905	0.15282225912528663
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00152905	0.15282225912528663
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00152905	0.15282225912528663
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00152905	0.15282225912528663
CZEIZEL-LOSONCI SYNDROME	0.00152905	0.15282225912528663
BRANCHIOOTORENAL SYNDROME 1	0.00152905	0.15282225912528663
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00152905	0.15282225912528663
TYPICAL NEMALINE MYOPATHY	0.00152905	0.15282225912528663
%106995 ANONYCHIA-ONYCHODYSTROPHY WITH HYPOPLASIA OR ABSENCE OF DISTAL PHALANGES;;COOKS SYNDROME	0.00152905	0.15282225912528663
AUTOSOMAL AGAMMAGLOBULINEMIA	0.00152905	0.15282225912528663
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00152905	0.15282225912528663
TRISOMY 8Q	0.00152905	0.15282225912528663
SHOX-RELATED SHORT STATURE	0.00152905	0.15282225912528663
MOEBIUS SYNDROME	0.00152905	0.15282225912528663
1Q44 MICRODELETION SYNDROME	0.00152905	0.15282225912528663
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00152905	0.15282225912528663
6Q16 MICRODELETION SYNDROME	0.00152905	0.15282225912528663
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.00152905	0.15282225912528663
DISTAL TRISOMY 18Q	0.00152905	0.15282225912528663
ADULT-ONSET NEMALINE MYOPATHY	0.00152905	0.15282225912528663
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00152905	0.15282225912528663
NATIVE AMERICAN MYOPATHY	0.00152905	0.15282225912528663
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00152905	0.15282225912528663
ATELOSTEOGENESIS TYPE III	0.00152905	0.15282225912528663
EVEN-PLUS SYNDROME	0.00152905	0.15282225912528663
MARTSOLF SYNDROME	0.00152905	0.15282225912528663
NON-DISTAL TRISOMY 13Q	0.00152905	0.15282225912528663
NON-DISTAL TRISOMY 10Q	0.00152905	0.15282225912528663
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00152905	0.15282225912528663
LAING EARLY-ONSET DISTAL MYOPATHY	0.00152905	0.15282225912528663
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00152905	0.15282225912528663
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.00152905	0.15282225912528663
EMERY-NELSON SYNDROME	0.00152905	0.15282225912528663
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00152905	0.15282225912528663
DISPROPORTIONATE SHORT STATURE WITH PTOSIS AND VALVULAR HEART LESIONS	0.00152905	0.15282225912528663
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.00152905	0.15282225912528663
AORTIC ANEURYSM, FAMILIAL THORACIC 9; AAT9	0.00152905	0.15282225912528663
ASCHER SYNDROME	0.00152905	0.15282225912528663
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.00152905	0.15282225912528663
FRONTOOCULAR SYNDROME	0.00152905	0.15282225912528663
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.00152905	0.15282225912528663
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00152905	0.15282225912528663
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00152905	0.15282225912528663
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00152905	0.15282225912528663
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.00152905	0.15282225912528663
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.00152905	0.15282225912528663
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00152905	0.15282225912528663
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.00152905	0.15282225912528663
BRANCHIO-OCULO-FACIAL SYNDROME	0.00152905	0.15282225912528663
ISCHIOCOXOPODOPATELLAR SYNDROME WITH OR WITHOUT PULMONARY ARTERIAL HYPERTENSION	0.00152905	0.15282225912528663
RAINE SYNDROME	0.00152905	0.15282225912528663
14Q11.2 MICRODELETION SYNDROME	0.00152905	0.15282225912528663
LETHAL CONGENITAL CONTRACTURE SYNDROME 10; LCCS10	0.00152905	0.15282225912528663
SWEENEY-COX SYNDROME; SWCOS	0.00152905	0.15282225912528663
BALLER-GEROLD SYNDROME	0.00152905	0.15282225912528663
LANGER MESOMELIC DYSPLASIA	0.00152905	0.15282225912528663
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.00152905	0.15282225912528663
MARFANOID HYPERMOBILITY SYNDROME	0.00152905	0.15282225912528663
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00152905	0.15282225912528663
CLEFT, MEDIAN, OF UPPER LIP WITH POLYPS OF FACIAL SKIN AND NASAL MUCOSA	0.00152905	0.15282225912528663
SAY-BARBER-MILLER SYNDROME	0.00152905	0.15282225912528663
TREACHER-COLLINS SYNDROME	0.00152905	0.15282225912528663
OROFACIODIGITAL SYNDROME VIII; OFD8	0.00152905	0.15282225912528663
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00152905	0.15282225912528663
NEU-LAXOVA SYNDROME 2; NLS2	0.00152905	0.15282225912528663
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00152905	0.15282225912528663
ACRO-RENAL-MANDIBULAR SYNDROME	0.00152905	0.15282225912528663
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.00152905	0.15282225912528663
2Q32Q33 MICRODELETION SYNDROME	0.00152905	0.15282225912528663
LERI-WEILL DYSCHONDROSTEOSIS	0.00152905	0.15282225912528663
NOONAN SYNDROME	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00152905	0.15282225912528663
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 3B, FAST-CHANNEL; CMS3B	0.00152905	0.15282225912528663
ULBRIGHT-HODES SYNDROME	0.00152905	0.15282225912528663
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00152905	0.15282225912528663
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.00152905	0.15282225912528663
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.00152905	0.15282225912528663
RAPADILINO SYNDROME	0.00152905	0.15282225912528663
WEYERS ULNAR RAY/OLIGODACTYLY SYNDROME	0.00152905	0.15282225912528663
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00152905	0.15282225912528663
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00152905	0.15282225912528663
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.00152905	0.15282225912528663
FRONTOMETAPHYSEAL DYSPLASIA	0.00152905	0.15282225912528663
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00152905	0.15282225912528663
MARSHALL SYNDROME	0.00152905	0.15282225912528663
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00152905	0.15282225912528663
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00152905	0.15282225912528663
RIN2 SYNDROME	0.00152905	0.15282225912528663
GABRIELE-DE VRIES SYNDROME	0.00152905	0.15282225912528663
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.00152905	0.15282225912528663
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00152905	0.15282225912528663
RHIZOMELIC SYNDROME, URBACH TYPE	0.00152905	0.15282225912528663
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.001502957	0.15021437108542132
PSEUDO-TORCH SYNDROME 2	0.001502957	0.15021437108542132
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001502957	0.15021437108542132
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.001502957	0.15021437108542132
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.001502957	0.15021437108542132
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.001502957	0.15021437108542132
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001502957	0.15021437108542132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.001502957	0.15021437108542132
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.001502957	0.15021437108542132
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001502957	0.15021437108542132
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.001502957	0.15021437108542132
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001502957	0.15021437108542132
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.001502957	0.15021437108542132
INFANTILE LIVER FAILURE SYNDROME 1	0.001502957	0.15021437108542132
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.001502957	0.15021437108542132
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.001502957	0.15021437108542132
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001502957	0.15021437108542132
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.001502957	0.15021437108542132
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.001502957	0.15021437108542132
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001502957	0.15021437108542132
ADAMS-OLIVER SYNDROME 2; AOS2	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001502957	0.15021437108542132
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001502957	0.15021437108542132
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.001502957	0.15021437108542132
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001502957	0.15021437108542132
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001502957	0.15021437108542132
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001502957	0.15021437108542132
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001502957	0.15021437108542132
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001502957	0.15021437108542132
VICI SYNDROME; VICIS	0.001502957	0.15021437108542132
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.001502957	0.15021437108542132
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.15021437108542132
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001502957	0.15021437108542132
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.001502957	0.15021437108542132
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.001502957	0.15021437108542132
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001502957	0.15021437108542132
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.15021437108542132
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.15021437108542132
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.001502957	0.15021437108542132
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001502957	0.15021437108542132
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001502957	0.15021437108542132
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001502957	0.15021437108542132
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.001502957	0.15021437108542132
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001502957	0.15021437108542132
HYPOPHOSPHATASIA, INFANTILE	0.001502957	0.15021437108542132
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.15021437108542132
MOWAT-WILSON SYNDROME; MOWS	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.15021437108542132
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001502957	0.15021437108542132
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001502957	0.15021437108542132
SIALIDOSIS TYPE 2	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.001502957	0.15021437108542132
SCHINDLER DISEASE, TYPE I	0.001502957	0.15021437108542132
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001502957	0.15021437108542132
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001502957	0.15021437108542132
SPINOCEREBELLAR ATAXIA TYPE 13	0.001502957	0.15021437108542132
GLUTARIC ACIDEMIA I; GA1	0.001502957	0.15021437108542132
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.001502957	0.15021437108542132
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001502957	0.15021437108542132
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001502957	0.15021437108542132
SHUKLA-VERNON SYNDROME; SHUVER	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.001502957	0.15021437108542132
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001502957	0.15021437108542132
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001502957	0.15021437108542132
XYLOSIDASE DEFICIENCY	0.001502957	0.15021437108542132
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001502957	0.15021437108542132
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.001502957	0.15021437108542132
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001502957	0.15021437108542132
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001502957	0.15021437108542132
GLUTAMINE DEFICIENCY, CONGENITAL	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001502957	0.15021437108542132
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001502957	0.15021437108542132
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001502957	0.15021437108542132
KLEEFSTRA SYNDROME	0.001502957	0.15021437108542132
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.001502957	0.15021437108542132
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001502957	0.15021437108542132
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001502957	0.15021437108542132
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001502957	0.15021437108542132
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001502957	0.15021437108542132
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001502957	0.15021437108542132
NON-DISTAL MONOSOMY 20Q	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001502957	0.15021437108542132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001502957	0.15021437108542132
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001502957	0.15021437108542132
HUNTINGTON DISEASE-LIKE 1	0.001502957	0.15021437108542132
TEMTAMY SYNDROME; TEMTYS	0.001502957	0.15021437108542132
RING CHROMOSOME 22 SYNDROME	0.001502957	0.15021437108542132
VISCERAL STEATOSIS, CONGENITAL	0.001502957	0.15021437108542132
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.001502957	0.15021437108542132
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001502957	0.15021437108542132
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001502957	0.15021437108542132
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001502957	0.15021437108542132
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.001502957	0.15021437108542132
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001502957	0.15021437108542132
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.001502957	0.15021437108542132
SULFOCYSTEINURIA	0.001502957	0.15021437108542132
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001502957	0.15021437108542132
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001502957	0.15021437108542132
COACH SYNDROME	0.001502957	0.15021437108542132
TAY-SACHS DISEASE; TSD	0.001502957	0.15021437108542132
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.001502957	0.15021437108542132
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001502957	0.15021437108542132
TRISOMY 8P	0.001502957	0.15021437108542132
ANGELMAN SYNDROME	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.001502957	0.15021437108542132
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001502957	0.15021437108542132
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.001502957	0.15021437108542132
LISSENCEPHALY 3; LIS3	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001502957	0.15021437108542132
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001502957	0.15021437108542132
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001502957	0.15021437108542132
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.001502957	0.15021437108542132
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001502957	0.15021437108542132
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001502957	0.15021437108542132
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001502957	0.15021437108542132
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001502957	0.15021437108542132
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001502957	0.15021437108542132
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001502957	0.15021437108542132
DDOST-CDG	0.001502957	0.15021437108542132
XQ25 MICRODUPLICATION SYNDROME	0.001502957	0.15021437108542132
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001502957	0.15021437108542132
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001502957	0.15021437108542132
EPISODIC ATAXIA, TYPE 6	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.001502957	0.15021437108542132
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001502957	0.15021437108542132
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001502957	0.15021437108542132
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001502957	0.15021437108542132
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001502957	0.15021437108542132
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001502957	0.15021437108542132
RAPID-ONSET DYSTONIA-PARKINSONISM	0.001502957	0.15021437108542132
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.15021437108542132
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.001502957	0.15021437108542132
COFFIN-SIRIS SYNDROME 8; CSS8	0.001502957	0.15021437108542132
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001502957	0.15021437108542132
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001502957	0.15021437108542132
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001502957	0.15021437108542132
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001502957	0.15021437108542132
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001502957	0.15021437108542132
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001502957	0.15021437108542132
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001502957	0.15021437108542132
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001502957	0.15021437108542132
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001486472	0.14856676313167202
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.001486472	0.14856676313167202
WARBURG MICRO SYNDROME 1	0.001486472	0.14856676313167202
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.001486472	0.14856676313167202
GIANT AXONAL NEUROPATHY	0.001486472	0.14856676313167202
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.001486472	0.14856676313167202
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001486472	0.14856676313167202
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.001486472	0.14856676313167202
HAREL-YOON SYNDROME; HAYOS	0.001486472	0.14856676313167202
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.001486472	0.14856676313167202
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001486472	0.14856676313167202
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.001486472	0.14856676313167202
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001486472	0.14856676313167202
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001486472	0.14856676313167202
OPTIC ATROPHY 11; OPA11	0.001486472	0.14856676313167202
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001486472	0.14856676313167202
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.001486472	0.14856676313167202
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001486472	0.14856676313167202
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.001486472	0.14856676313167202
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.001486472	0.14856676313167202
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001486472	0.14856676313167202
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.001486472	0.14856676313167202
MENTAL RETARDATION, X-LINKED 12; MRX12	0.001486472	0.14856676313167202
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001486472	0.14856676313167202
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001486472	0.14856676313167202
MENTAL RETARDATION, X-LINKED 41	0.001486472	0.14856676313167202
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.001486472	0.14856676313167202
PERIPHERAL HYPOTHYROIDISM	0.001486472	0.14856676313167202
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.001486472	0.14856676313167202
LESCH-NYHAN SYNDROME; LNS	0.001486472	0.14856676313167202
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.001486472	0.14856676313167202
LAMB-SHAFFER SYNDROME	0.001486472	0.14856676313167202
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.001486472	0.14856676313167202
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.001486472	0.14856676313167202
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.001486472	0.14856676313167202
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.001486472	0.14856676313167202
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.001486472	0.14856676313167202
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001486472	0.14856676313167202
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.001486472	0.14856676313167202
DISTAL MONOSOMY 12Q	0.001486472	0.14856676313167202
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.001486472	0.14856676313167202
SIFRIM-HITZ-WEISS SYNDROME	0.001486472	0.14856676313167202
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.001486472	0.14856676313167202
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.001486472	0.14856676313167202
MICROTRIPLICATION 11Q24.1	0.001486472	0.14856676313167202
JOUBERT SYNDROME 27	0.001486472	0.14856676313167202
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.001486472	0.14856676313167202
JOUBERT SYNDROME 5	0.001486472	0.14856676313167202
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001486472	0.14856676313167202
JOUBERT SYNDROME 6	0.001486472	0.14856676313167202
COFFIN-SIRIS SYNDROME 10; CSS10	0.001486472	0.14856676313167202
GOLDBERG-SHPRINTZEN SYNDROME	0.001486472	0.14856676313167202
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.001486472	0.14856676313167202
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001486472	0.14856676313167202
COFFIN-SIRIS SYNDROME 6; CSS6	0.001486472	0.14856676313167202
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.001486472	0.14856676313167202
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.001486472	0.14856676313167202
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001486472	0.14856676313167202
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.001486472	0.14856676313167202
JOUBERT SYNDROME 3; JBTS3	0.001486472	0.14856676313167202
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001486472	0.14856676313167202
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.001486472	0.14856676313167202
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.001486472	0.14856676313167202
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.001486472	0.14856676313167202
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.001486472	0.14856676313167202
DESBUQUOIS DYSPLASIA 1	0.001486472	0.14856676313167202
JOUBERT SYNDROME 8	0.001486472	0.14856676313167202
XIA-GIBBS SYNDROME	0.001486472	0.14856676313167202
MUCOLIPIDOSIS IV; ML4	0.001486472	0.14856676313167202
MARINESCO-SJOGREN SYNDROME; MSS	0.001486472	0.14856676313167202
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.001486472	0.14856676313167202
JOUBERT SYNDROME 7	0.001486472	0.14856676313167202
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.001486472	0.14856676313167202
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001486472	0.14856676313167202
JOUBERT SYNDROME 28	0.001486472	0.14856676313167202
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001486472	0.14856676313167202
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001486472	0.14856676313167202
NIEMANN-PICK DISEASE, TYPE A	0.001486472	0.14856676313167202
JOHANSON-BLIZZARD SYNDROME; JBS	0.001486472	0.14856676313167202
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.001486472	0.14856676313167202
PEROXISOME BIOGENESIS DISORDER 3B	0.001486472	0.14856676313167202
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001486472	0.14856676313167202
SOTOS SYNDROME 2	0.001486472	0.14856676313167202
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001486472	0.14856676313167202
GALACTOSE EPIMERASE DEFICIENCY	0.001486472	0.14856676313167202
HYPERCALCEMIA, INFANTILE, 1	0.001486472	0.14856676313167202
JOUBERT SYNDROME 21	0.001486472	0.14856676313167202
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.001486472	0.14856676313167202
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001486472	0.14856676313167202
SPINOCEREBELLAR ATAXIA 13	0.001486472	0.14856676313167202
SHWACHMAN-DIAMOND SYNDROME	0.001486472	0.14856676313167202
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001486472	0.14856676313167202
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001486472	0.14856676313167202
JACOBSEN SYNDROME	0.001486472	0.14856676313167202
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.001486472	0.14856676313167202
CHROMOSOME 9P DELETION SYNDROME	0.001486472	0.14856676313167202
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.001486472	0.14856676313167202
JOUBERT SYNDROME 15	0.001486472	0.14856676313167202
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001486472	0.14856676313167202
OSTEOPENIA AND SPARSE HAIR	0.001486472	0.14856676313167202
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001486472	0.14856676313167202
PRIMROSE SYNDROME; PRIMS	0.001486472	0.14856676313167202
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001066353	0.10657759686408344
RAMON SYNDROME	0.001066353	0.10657759686408344
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.001066353	0.10657759686408344
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.001066353	0.10657759686408344
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001066353	0.10657759686408344
CITRULLINEMIA, CLASSIC	0.001066353	0.10657759686408344
COFFIN-SIRIS SYNDROME 5	0.001066353	0.10657759686408344
GENITOPATELLAR SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001066353	0.10657759686408344
ATYPICAL RETT SYNDROME	0.001066353	0.10657759686408344
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.001066353	0.10657759686408344
CROME SYNDROME	0.001066353	0.10657759686408344
COCKAYNE SYNDROME A; CSA	0.001066353	0.10657759686408344
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.001066353	0.10657759686408344
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001066353	0.10657759686408344
11P15.4 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.001066353	0.10657759686408344
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001066353	0.10657759686408344
MAPLE SYRUP URINE DISEASE	0.001066353	0.10657759686408344
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.001066353	0.10657759686408344
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.10657759686408344
NEUROCUTANEOUS MELANOCYTOSIS	0.001066353	0.10657759686408344
KOOLEN-DE VRIES SYNDROME	0.001066353	0.10657759686408344
PAPILLORENAL SYNDROME	0.001066353	0.10657759686408344
1P36 DELETION SYNDROME	0.001066353	0.10657759686408344
2Q24 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.001066353	0.10657759686408344
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001066353	0.10657759686408344
WOLCOTT-RALLISON SYNDROME	0.001066353	0.10657759686408344
17Q11.2 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.001066353	0.10657759686408344
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001066353	0.10657759686408344
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001066353	0.10657759686408344
49,XXXXY SYNDROME	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.001066353	0.10657759686408344
22Q11.2 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.001066353	0.10657759686408344
CROUZON SYNDROME	0.001066353	0.10657759686408344
RECOMBINANT 8 SYNDROME	0.001066353	0.10657759686408344
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.001066353	0.10657759686408344
1Q21.1 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
MOYAMOYA DISEASE	0.001066353	0.10657759686408344
PITUITARY STALK INTERRUPTION SYNDROME	0.001066353	0.10657759686408344
MYHRE SYNDROME	0.001066353	0.10657759686408344
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
RING CHROMOSOME 10 SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, FRA12A TYPE	0.001066353	0.10657759686408344
COFFIN-SIRIS SYNDROME	0.001066353	0.10657759686408344
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.001066353	0.10657759686408344
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001066353	0.10657759686408344
DISTAL MONOSOMY 19P13.3	0.001066353	0.10657759686408344
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001066353	0.10657759686408344
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001066353	0.10657759686408344
2Q31.1 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
1Q41Q42 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
15Q11Q13 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
DYSEQUILIBRIUM SYNDROME	0.001066353	0.10657759686408344
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
JOUBERT SYNDROME WITH RENAL DEFECT	0.001066353	0.10657759686408344
ANGELMAN SYNDROME (TYPE 2)	0.001066353	0.10657759686408344
CONGENITAL HYDROCEPHALUS	0.001066353	0.10657759686408344
DERMOTRICHIC SYNDROME	0.001066353	0.10657759686408344
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001066353	0.10657759686408344
ANGELMAN SYNDROME (TYPE 1)	0.001066353	0.10657759686408344
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.001066353	0.10657759686408344
HADDAD SYNDROME	0.001066353	0.10657759686408344
POTOCKI-SHAFFER SYNDROME	0.001066353	0.10657759686408344
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.001066353	0.10657759686408344
HARTNUP DISEASE	0.001066353	0.10657759686408344
CYSTATHIONINURIA	0.001066353	0.10657759686408344
1P36 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
HENNEKAM SYNDROME	0.001066353	0.10657759686408344
DONNAI-BARROW SYNDROME	0.001066353	0.10657759686408344
NEURONAL CEROID LIPOFUSCINOSIS	0.001066353	0.10657759686408344
JOUBERT SYNDROME WITH OCULAR DEFECT	0.001066353	0.10657759686408344
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
SANJAD-SAKATI SYNDROME	0.001066353	0.10657759686408344
ACROCARDIOFACIAL SYNDROME	0.001066353	0.10657759686408344
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.001066353	0.10657759686408344
ACROMELIC FRONTONASAL DYSPLASIA	0.001066353	0.10657759686408344
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.001066353	0.10657759686408344
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001066353	0.10657759686408344
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.001066353	0.10657759686408344
EDINBURGH MALFORMATION SYNDROME	0.001066353	0.10657759686408344
COCKAYNE SYNDROME	0.001066353	0.10657759686408344
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.001066353	0.10657759686408344
15Q13.3 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
COHEN SYNDROME	0.001066353	0.10657759686408344
5Q35 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001066353	0.10657759686408344
EPILEPSY-TELANGIECTASIA SYNDROME	0.001066353	0.10657759686408344
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.001066353	0.10657759686408344
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.001066353	0.10657759686408344
MOYNAHAN SYNDROME	0.001066353	0.10657759686408344
COG8-CDG	0.001066353	0.10657759686408344
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001066353	0.10657759686408344
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.001066353	0.10657759686408344
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001066353	0.10657759686408344
WALKER-WARBURG SYNDROME	0.001066353	0.10657759686408344
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.001066353	0.10657759686408344
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001066353	0.10657759686408344
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001066353	0.10657759686408344
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
TYROSINEMIA TYPE 2	0.001066353	0.10657759686408344
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001066353	0.10657759686408344
TUBEROUS SCLEROSIS-1	0.001066353	0.10657759686408344
CEREBROTENDINOUS XANTHOMATOSIS	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001066353	0.10657759686408344
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001066353	0.10657759686408344
SUPRABULBAR PARESIS, CONGENITAL	0.001066353	0.10657759686408344
STURGE-WEBER SYNDROME	0.001066353	0.10657759686408344
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.001066353	0.10657759686408344
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.001066353	0.10657759686408344
ARGININOSUCCINIC ACIDURIA	0.001066353	0.10657759686408344
MEVALONIC ACIDURIA	0.001066353	0.10657759686408344
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001066353	0.10657759686408344
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001066353	0.10657759686408344
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.001066353	0.10657759686408344
LISSENCEPHALY 8; LIS8	0.001066353	0.10657759686408344
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001066353	0.10657759686408344
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001066353	0.10657759686408344
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.001066353	0.10657759686408344
LEUKOCYTE ADHESION DEFICIENCY	0.001066353	0.10657759686408344
BANGSTAD SYNDROME	0.001066353	0.10657759686408344
PORENCEPHALY	0.001066353	0.10657759686408344
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.001066353	0.10657759686408344
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001066353	0.10657759686408344
DPAGT1-CDG	0.001066353	0.10657759686408344
AUTISM	0.001066353	0.10657759686408344
CONGENITAL RUBELLA SYNDROME	0.001066353	0.10657759686408344
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001066353	0.10657759686408344
ALG11-CDG	0.001066353	0.10657759686408344
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.001066353	0.10657759686408344
ASPARTYLGLUCOSAMINURIA	0.001066353	0.10657759686408344
SMITH-FINEMAN-MYERS SYNDROME	0.001066353	0.10657759686408344
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001066353	0.10657759686408344
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.001066353	0.10657759686408344
XP21 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001066353	0.10657759686408344
KBG SYNDROME	0.001066353	0.10657759686408344
21Q22.11Q22.12 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001066353	0.10657759686408344
17Q12 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
17Q12 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
LINEAR NEVUS SEBACEUS SYNDROME	0.001066353	0.10657759686408344
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.001066353	0.10657759686408344
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.001066353	0.10657759686408344
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.001066353	0.10657759686408344
BETA-MANNOSIDOSIS	0.001066353	0.10657759686408344
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001066353	0.10657759686408344
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.001066353	0.10657759686408344
OCULODENTODIGITAL DYSPLASIA; ODDD	0.001066353	0.10657759686408344
OCULOCEREBROCUTANEOUS SYNDROME	0.001066353	0.10657759686408344
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
2Q37 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.001066353	0.10657759686408344
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.001066353	0.10657759686408344
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.001066353	0.10657759686408344
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
L1 SYNDROME	0.001066353	0.10657759686408344
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.001066353	0.10657759686408344
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.001066353	0.10657759686408344
OCULODENTODIGITAL DYSPLASIA	0.001066353	0.10657759686408344
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001066353	0.10657759686408344
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001066353	0.10657759686408344
224250 DYSMYELINATION WITH JAUNDICE	0.001066353	0.10657759686408344
WOLF-HIRSCHHORN SYNDROME	0.001066353	0.10657759686408344
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001066353	0.10657759686408344
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.001066353	0.10657759686408344
GALACTOSEMIA	0.001066353	0.10657759686408344
HYPERLEUCINE-ISOLEUCINEMIA	0.001066353	0.10657759686408344
HYPERLYSINEMIA, TYPE I	0.001066353	0.10657759686408344
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001066353	0.10657759686408344
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.001066353	0.10657759686408344
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.001066353	0.10657759686408344
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.001066353	0.10657759686408344
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.001066353	0.10657759686408344
RAMON SYNDROME	0.001066353	0.10657759686408344
ACQUIRED PARTIAL LIPODYSTROPHY	0.001066353	0.10657759686408344
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001066353	0.10657759686408344
PIERPONT SYNDROME	0.001066353	0.10657759686408344
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001066353	0.10657759686408344
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.001066353	0.10657759686408344
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.001066353	0.10657759686408344
TETRASOMY 18P	0.001066353	0.10657759686408344
GLUTATHIONE SYNTHETASE DEFICIENCY	0.001066353	0.10657759686408344
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.001066353	0.10657759686408344
LEBER CONGENITAL AMAUROSIS	0.001066353	0.10657759686408344
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001066353	0.10657759686408344
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.001066353	0.10657759686408344
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001066353	0.10657759686408344
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001066353	0.10657759686408344
611961 STEVENSON-CAREY SYNDROME	0.001066353	0.10657759686408344
POTOCKI-SHAFFER SYNDROME	0.001066353	0.10657759686408344
FILIPPI SYNDROME; FLPIS	0.001066353	0.10657759686408344
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.001066353	0.10657759686408344
RENPENNING SYNDROME	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.001066353	0.10657759686408344
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001066353	0.10657759686408344
INCONTINENTIA PIGMENTI	0.001066353	0.10657759686408344
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.001066353	0.10657759686408344
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001066353	0.10657759686408344
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.001066353	0.10657759686408344
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.001066353	0.10657759686408344
SRD5A3-CDG	0.001066353	0.10657759686408344
ZLOTOGORA-OGUR SYNDROME	0.001066353	0.10657759686408344
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001066353	0.10657759686408344
CHROMOSOME 2Q37 DELETION SYNDROME	0.001066353	0.10657759686408344
FAMILIAL MULTIPLE NEVI FLAMMEI	0.001066353	0.10657759686408344
NETHERTON SYNDROME	0.001066353	0.10657759686408344
ALSTRÃ–M SYNDROME	0.001066353	0.10657759686408344
SJOGREN-LARSSON SYNDROME; SLS	0.001066353	0.10657759686408344
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.001066353	0.10657759686408344
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.001066353	0.10657759686408344
AYME-GRIPP SYNDROME; AYGRP	0.001066353	0.10657759686408344
GURRIERI SYNDROME	0.001066353	0.10657759686408344
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.001066353	0.10657759686408344
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001066353	0.10657759686408344
HYPERPROLINEMIA, TYPE II	0.001066353	0.10657759686408344
GALACTOSIALIDOSIS	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001066353	0.10657759686408344
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.001066353	0.10657759686408344
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001066353	0.10657759686408344
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.001066353	0.10657759686408344
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.001066353	0.10657759686408344
PRIMARY CUTIS VERTICIS GYRATA	0.001066353	0.10657759686408344
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.001066353	0.10657759686408344
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001066353	0.10657759686408344
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001066353	0.10657759686408344
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.001066353	0.10657759686408344
BARAITSER-WINTER SYNDROME 2; BRWS2	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.001066353	0.10657759686408344
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.001066353	0.10657759686408344
WOLFRAM SYNDROME	0.001066353	0.10657759686408344
CRIGLER-NAJJAR SYNDROME TYPE 1	0.001066353	0.10657759686408344
ATYPICAL JUVENILE PARKINSONISM	0.001066353	0.10657759686408344
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001066353	0.10657759686408344
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001066353	0.10657759686408344
WILSON-TURNER SYNDROME	0.001066353	0.10657759686408344
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.001066353	0.10657759686408344
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.001066353	0.10657759686408344
LISSENCEPHALY 1; LIS1	0.001066353	0.10657759686408344
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001066353	0.10657759686408344
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.001066353	0.10657759686408344
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.001066353	0.10657759686408344
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.001066353	0.10657759686408344
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.001066353	0.10657759686408344
LANDAU-KLEFFNER SYNDROME	0.001066353	0.10657759686408344
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001066353	0.10657759686408344
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001066353	0.10657759686408344
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001066353	0.10657759686408344
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001066353	0.10657759686408344
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.001066353	0.10657759686408344
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001066353	0.10657759686408344
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001066353	0.10657759686408344
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001066353	0.10657759686408344
KIFAFA SEIZURE DISORDER	0.001066353	0.10657759686408344
PHENYLKETONURIA	0.001066353	0.10657759686408344
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001066353	0.10657759686408344
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001066353	0.10657759686408344
CEDNIK SYNDROME	0.001066353	0.10657759686408344
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001066353	0.10657759686408344
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.001066353	0.10657759686408344
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001066353	0.10657759686408344
GRISCELLI SYNDROME	0.001066353	0.10657759686408344
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.001066353	0.10657759686408344
SCHIZENCEPHALY	0.001066353	0.10657759686408344
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.001066353	0.10657759686408344
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.001066353	0.10657759686408344
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 88	0.001066353	0.10657759686408344
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.001066353	0.10657759686408344
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001066353	0.10657759686408344
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001066353	0.10657759686408344
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001066353	0.10657759686408344
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.001066353	0.10657759686408344
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001066353	0.10657759686408344
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001066353	0.10657759686408344
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.001066353	0.10657759686408344
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001066353	0.10657759686408344
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001066353	0.10657759686408344
SMITH-MAGENIS SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.001066353	0.10657759686408344
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001066353	0.10657759686408344
SMITH-LEMLI-OPITZ SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 96; MRX96	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 72	0.001066353	0.10657759686408344
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001066353	0.10657759686408344
SJÃ–GREN-LARSSON SYNDROME	0.001066353	0.10657759686408344
FREE SIALIC ACID STORAGE DISEASE	0.001066353	0.10657759686408344
WYBURN-MASON SYNDROME	0.001066353	0.10657759686408344
TUBEROUS SCLEROSIS 2; TSC2	0.001066353	0.10657759686408344
PROTEUS SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.001066353	0.10657759686408344
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001066353	0.10657759686408344
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.001066353	0.10657759686408344
EPILEPSY-TELANGIECTASIA	0.001066353	0.10657759686408344
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001066353	0.10657759686408344
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001066353	0.10657759686408344
IMMUNODEFICIENCY 47	0.001066353	0.10657759686408344
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.001066353	0.10657759686408344
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 103	0.001066353	0.10657759686408344
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.001066353	0.10657759686408344
OCULOCEREBRORENAL SYNDROME OF LOWE	0.001066353	0.10657759686408344
SEVERE CANAVAN DISEASE	0.001066353	0.10657759686408344
ISOLATED SPINA BIFIDA	0.001066353	0.10657759686408344
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001066353	0.10657759686408344
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.001066353	0.10657759686408344
16P13.2 MICRODELETION SYNDROME	0.001066353	0.10657759686408344
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.001066353	0.10657759686408344
FRYNS SYNDROME; FRNS	0.001066353	0.10657759686408344
FOUNTAIN SYNDROME	0.001066353	0.10657759686408344
CRANIOPHARYNGIOMA	0.001066353	0.10657759686408344
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.001066353	0.10657759686408344
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.001066353	0.10657759686408344
MENKES DISEASE	0.001066353	0.10657759686408344
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.001066353	0.10657759686408344
CAMOS SYNDROME	0.001066353	0.10657759686408344
MICROPHTHALMIA, LENZ TYPE	0.001066353	0.10657759686408344
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.001066353	0.10657759686408344
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001066353	0.10657759686408344
JOUBERT SYNDROME	0.001066353	0.10657759686408344
METACHROMATIC LEUKODYSTROPHY	0.001066353	0.10657759686408344
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.001066353	0.10657759686408344
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001066353	0.10657759686408344
311450 PALLISTER W SYNDROME;;W SYNDROME	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 82	0.001066353	0.10657759686408344
FOUNTAIN SYNDROME	0.001066353	0.10657759686408344
RUVALCABA SYNDROME	0.001066353	0.10657759686408344
WAISMAN SYNDROME; WSMN	0.001066353	0.10657759686408344
MULTIPLE SULFATASE DEFICIENCY	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.001066353	0.10657759686408344
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.001066353	0.10657759686408344
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.001066353	0.10657759686408344
STURGE-WEBER SYNDROME	0.001066353	0.10657759686408344
LOWE OCULOCEREBRORENAL SYNDROME	0.001066353	0.10657759686408344
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.001066353	0.10657759686408344
MONOSOMY 22Q13.3	0.001066353	0.10657759686408344
GLYCEROL KINASE DEFICIENCY; GKD	0.001066353	0.10657759686408344
GAPO SYNDROME; GAPOS	0.001066353	0.10657759686408344
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001066353	0.10657759686408344
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001066353	0.10657759686408344
SIALIDOSIS TYPE 1	0.001066353	0.10657759686408344
ICHTHYOSIS AND MALE HYPOGONADISM	0.001066353	0.10657759686408344
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.001066353	0.10657759686408344
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.001066353	0.10657759686408344
INCONTINENTIA PIGMENTI; IP	0.001066353	0.10657759686408344
HEREDITARY HYPEREKPLEXIA	0.001066353	0.10657759686408344
MENTAL RETARDATION, X-LINKED 100	0.001066353	0.10657759686408344
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001066353	0.10657759686408344
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.09610176867650494
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA 1	0.0009615380000000001	0.09610176867650494
NOONAN SYNDROME 11; NS11	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 4	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.0009615380000000001	0.09610176867650494
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.0009615380000000001	0.09610176867650494
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.09610176867650494
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.0009615380000000001	0.09610176867650494
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0009615380000000001	0.09610176867650494
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.0009615380000000001	0.09610176867650494
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.0009615380000000001	0.09610176867650494
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.09610176867650494
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.09610176867650494
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.0009615380000000001	0.09610176867650494
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.09610176867650494
COMBINED SAPOSIN DEFICIENCY	0.0009615380000000001	0.09610176867650494
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0009615380000000001	0.09610176867650494
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.0009615380000000001	0.09610176867650494
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.09610176867650494
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0009615380000000001	0.09610176867650494
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.09610176867650494
SHPRINTZEN OMPHALOCELE SYNDROME	0.0009615380000000001	0.09610176867650494
METHYLMALONIC ACIDURIA, CBLB TYPE	0.0009615380000000001	0.09610176867650494
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.0009615380000000001	0.09610176867650494
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0009615380000000001	0.09610176867650494
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0009615380000000001	0.09610176867650494
MEVALONIC ACIDURIA; MEVA	0.0009615380000000001	0.09610176867650494
SALT-AND-PEPPER SYNDROME	0.0009615380000000001	0.09610176867650494
FONTAINE PROGEROID SYNDROME; FPS	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.0009615380000000001	0.09610176867650494
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.0009615380000000001	0.09610176867650494
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.09610176867650494
PIERSON SYNDROME	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.0009615380000000001	0.09610176867650494
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.09610176867650494
RIGID SPINE SYNDROME	0.0009615380000000001	0.09610176867650494
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.09610176867650494
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.0009615380000000001	0.09610176867650494
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.0009615380000000001	0.09610176867650494
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.09610176867650494
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.0009615380000000001	0.09610176867650494
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.09610176867650494
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0009615380000000001	0.09610176867650494
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.0009615380000000001	0.09610176867650494
CAMPOMELIC DYSPLASIA	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA 5; SCA5	0.0009615380000000001	0.09610176867650494
MULTIMINICORE MYOPATHY	0.0009615380000000001	0.09610176867650494
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.0009615380000000001	0.09610176867650494
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0009615380000000001	0.09610176867650494
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0009615380000000001	0.09610176867650494
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0009615380000000001	0.09610176867650494
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.09610176867650494
CRANIOFRONTONASAL SYNDROME; CFNS	0.0009615380000000001	0.09610176867650494
SCHOLTE SYNDROME; SHLTS	0.0009615380000000001	0.09610176867650494
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.09610176867650494
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA TYPE 29	0.0009615380000000001	0.09610176867650494
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.0009615380000000001	0.09610176867650494
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.09610176867650494
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0009615380000000001	0.09610176867650494
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.09610176867650494
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0009615380000000001	0.09610176867650494
AICARDI SYNDROME; AIC	0.0009615380000000001	0.09610176867650494
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0009615380000000001	0.09610176867650494
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.0009615380000000001	0.09610176867650494
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.09610176867650494
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA TYPE 1	0.0009615380000000001	0.09610176867650494
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.09610176867650494
STUVE-WIEDEMANN SYNDROME	0.0009615380000000001	0.09610176867650494
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.0009615380000000001	0.09610176867650494
HYPOTONIA-CYSTINURIA SYNDROME	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0009615380000000001	0.09610176867650494
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.0009615380000000001	0.09610176867650494
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	0.09610176867650494
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.09610176867650494
DIAPHANOSPONDYLODYSOSTOSIS	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.09610176867650494
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.09610176867650494
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0009615380000000001	0.09610176867650494
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.09610176867650494
MYOTONIC DYSTROPHY 1	0.0009615380000000001	0.09610176867650494
NAVAJO NEUROHEPATOPATHY	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0009615380000000001	0.09610176867650494
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.0009615380000000001	0.09610176867650494
GENITOPATELLAR SYNDROME; GTPTS	0.0009615380000000001	0.09610176867650494
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.0009615380000000001	0.09610176867650494
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0009615380000000001	0.09610176867650494
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.09610176867650494
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.09610176867650494
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.0009615380000000001	0.09610176867650494
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.09610176867650494
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.0009615380000000001	0.09610176867650494
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0009615380000000001	0.09610176867650494
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0009615380000000001	0.09610176867650494
PSEUDOTRISOMY 13 SYNDROME	0.0009615380000000001	0.09610176867650494
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.0009615380000000001	0.09610176867650494
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.0009615380000000001	0.09610176867650494
AURICULOCONDYLAR SYNDROME	0.0009615380000000001	0.09610176867650494
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.09610176867650494
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.09610176867650494
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.09610176867650494
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0009615380000000001	0.09610176867650494
SYDENHAM CHOREA	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.0009615380000000001	0.09610176867650494
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.09610176867650494
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.0009615380000000001	0.09610176867650494
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0009615380000000001	0.09610176867650494
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.0009615380000000001	0.09610176867650494
YOU-HOOVER-FONG SYNDROME; YHFS	0.0009615380000000001	0.09610176867650494
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.0009615380000000001	0.09610176867650494
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.09610176867650494
PEROXISOME BIOGENESIS DISORDER 5B	0.0009615380000000001	0.09610176867650494
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0009615380000000001	0.09610176867650494
PEROXISOME BIOGENESIS DISORDER 6B	0.0009615380000000001	0.09610176867650494
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0009615380000000001	0.09610176867650494
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0009615380000000001	0.09610176867650494
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.0009615380000000001	0.09610176867650494
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.09610176867650494
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.0009615380000000001	0.09610176867650494
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.0009615380000000001	0.09610176867650494
ETHANOLAMINOSIS	0.0009615380000000001	0.09610176867650494
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.0009615380000000001	0.09610176867650494
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.09610176867650494
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.0009615380000000001	0.09610176867650494
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.0009615380000000001	0.09610176867650494
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.0009615380000000001	0.09610176867650494
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 31; JBTS31	0.0009615380000000001	0.09610176867650494
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 14	0.0009615380000000001	0.09610176867650494
ARIMA SYNDROME	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0009615380000000001	0.09610176867650494
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0009615380000000001	0.09610176867650494
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.0009615380000000001	0.09610176867650494
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.09610176867650494
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.0009615380000000001	0.09610176867650494
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.0009615380000000001	0.09610176867650494
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	0.09610176867650494
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.09610176867650494
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.0009615380000000001	0.09610176867650494
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.09610176867650494
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.0009615380000000001	0.09610176867650494
ALG13-CDG	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.0009615380000000001	0.09610176867650494
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.09610176867650494
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.0009615380000000001	0.09610176867650494
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
CHITAYAT SYNDROME	0.0009615380000000001	0.09610176867650494
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.0009615380000000001	0.09610176867650494
PEROXISOME BIOGENESIS DISORDER 10B	0.0009615380000000001	0.09610176867650494
OROFACIODIGITAL SYNDROME XIV; OFD14	0.0009615380000000001	0.09610176867650494
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.0009615380000000001	0.09610176867650494
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.0009615380000000001	0.09610176867650494
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.09610176867650494
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0009615380000000001	0.09610176867650494
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.0009615380000000001	0.09610176867650494
TRICHOTHIODYSTROPHY	0.0009615380000000001	0.09610176867650494
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.0009615380000000001	0.09610176867650494
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.09610176867650494
SENGERS SYNDROME	0.0009615380000000001	0.09610176867650494
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.0009615380000000001	0.09610176867650494
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.09610176867650494
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.0009615380000000001	0.09610176867650494
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0009615380000000001	0.09610176867650494
RITSCHER-SCHINZEL SYNDROME 1	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.09610176867650494
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.09610176867650494
AL-RAQAD SYNDROME; ARS	0.0009615380000000001	0.09610176867650494
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.09610176867650494
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	0.09610176867650494
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.09610176867650494
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.09610176867650494
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.0009615380000000001	0.09610176867650494
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0009615380000000001	0.09610176867650494
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.09610176867650494
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.0009615380000000001	0.09610176867650494
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.0009615380000000001	0.09610176867650494
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0009615380000000001	0.09610176867650494
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 24	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.0009615380000000001	0.09610176867650494
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.09610176867650494
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
ROIFMAN SYNDROME	0.0009615380000000001	0.09610176867650494
SUSAC SYNDROME	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0009615380000000001	0.09610176867650494
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0009615380000000001	0.09610176867650494
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0009615380000000001	0.09610176867650494
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.0009615380000000001	0.09610176867650494
VERVERI-BRADY SYNDROME; VERBRAS	0.0009615380000000001	0.09610176867650494
NOONAN SYNDROME 6; NS6	0.0009615380000000001	0.09610176867650494
CRANIOSYNOSTOSIS 6; CRS6	0.0009615380000000001	0.09610176867650494
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.0009615380000000001	0.09610176867650494
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0009615380000000001	0.09610176867650494
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 35; JBTS35	0.0009615380000000001	0.09610176867650494
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.09610176867650494
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.0009615380000000001	0.09610176867650494
CHIARI MALFORMATION TYPE II	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.0009615380000000001	0.09610176867650494
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0009615380000000001	0.09610176867650494
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	0.09610176867650494
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.09610176867650494
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.0009615380000000001	0.09610176867650494
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.0009615380000000001	0.09610176867650494
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.0009615380000000001	0.09610176867650494
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.0009615380000000001	0.09610176867650494
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 26	0.0009615380000000001	0.09610176867650494
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.0009615380000000001	0.09610176867650494
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0009615380000000001	0.09610176867650494
JOUBERT SYNDROME 25	0.0009615380000000001	0.09610176867650494
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.0009615380000000001	0.09610176867650494
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
MICROPHTHALMIA, SYNDROMIC 3	0.0009615380000000001	0.09610176867650494
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.09610176867650494
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.0009615380000000001	0.09610176867650494
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.09610176867650494
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.09610176867650494
CHROMOSOME 4Q21 DELETION SYNDROME	0.0009615380000000001	0.09610176867650494
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.09610176867650494
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.0009615380000000001	0.09610176867650494
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.05411260240891637
SECONDARY SYRINGOMYELIA	0.000541419	0.05411260240891637
CHOREOACANTHOCYTOSIS	0.000541419	0.05411260240891637
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.05411260240891637
MUSCLE-EYE-BRAIN DISEASE	0.000541419	0.05411260240891637
MYASTHENIA GRAVIS	0.000541419	0.05411260240891637
WHIM SYNDROME	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE 3	0.000541419	0.05411260240891637
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.05411260240891637
TAY-SACHS DISEASE	0.000541419	0.05411260240891637
ISOLATED BILIARY ATRESIA	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.000541419	0.05411260240891637
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.05411260240891637
ENCEPHALITIS LETHARGICA	0.000541419	0.05411260240891637
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.05411260240891637
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.05411260240891637
CITRULLINEMIA TYPE I	0.000541419	0.05411260240891637
AICARDI-GOUTIÃˆRES SYNDROME	0.000541419	0.05411260240891637
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.05411260240891637
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.05411260240891637
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.000541419	0.05411260240891637
HOLOPROSENCEPHALY	0.000541419	0.05411260240891637
GRISCELLI SYNDROME TYPE 2	0.000541419	0.05411260240891637
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.05411260240891637
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.05411260240891637
NOCARDIOSIS	0.000541419	0.05411260240891637
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.05411260240891637
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.05411260240891637
RFT1-CDG	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.05411260240891637
SANDHOFF DISEASE	0.000541419	0.05411260240891637
CENTRONUCLEAR MYOPATHY	0.000541419	0.05411260240891637
CENTRAL BILATERAL MACROGYRIA	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS TYPE 2	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.000541419	0.05411260240891637
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.05411260240891637
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.05411260240891637
LOWRY-MACLEAN SYNDROME	0.000541419	0.05411260240891637
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.05411260240891637
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.05411260240891637
NIPAH VIRUS DISEASE	0.000541419	0.05411260240891637
NEPHROGENIC DIABETES INSIPIDUS	0.000541419	0.05411260240891637
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.000541419	0.05411260240891637
SLC39A8-CDG	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.000541419	0.05411260240891637
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.05411260240891637
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.05411260240891637
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.05411260240891637
MEHMO SYNDROME	0.000541419	0.05411260240891637
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.000541419	0.05411260240891637
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.05411260240891637
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.05411260240891637
15Q OVERGROWTH SYNDROME	0.000541419	0.05411260240891637
9Q33.3Q34.11 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
SNEDDON SYNDROME	0.000541419	0.05411260240891637
SCRUB TYPHUS	0.000541419	0.05411260240891637
2Q23.1 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.05411260240891637
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.05411260240891637
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.05411260240891637
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.05411260240891637
MILLER-DIEKER SYNDROME	0.000541419	0.05411260240891637
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.05411260240891637
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000541419	0.05411260240891637
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.000541419	0.05411260240891637
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.05411260240891637
ADRENOMYODYSTROPHY	0.000541419	0.05411260240891637
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.000541419	0.05411260240891637
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.05411260240891637
BOHRING-OPITZ SYNDROME	0.000541419	0.05411260240891637
4Q21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.05411260240891637
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.05411260240891637
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.05411260240891637
LASSA FEVER	0.000541419	0.05411260240891637
22Q11.2 DELETION SYNDROME	0.000541419	0.05411260240891637
LEIGH SYNDROME	0.000541419	0.05411260240891637
SCLERODERMA	0.000541419	0.05411260240891637
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.05411260240891637
INSULINOMA	0.000541419	0.05411260240891637
KBG SYNDROME	0.000541419	0.05411260240891637
KEUTEL SYNDROME	0.000541419	0.05411260240891637
KALLMANN SYNDROME	0.000541419	0.05411260240891637
DUANE RETRACTION SYNDROME	0.000541419	0.05411260240891637
HYDRANENCEPHALY	0.000541419	0.05411260240891637
ADDISON DISEASE	0.000541419	0.05411260240891637
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.000541419	0.05411260240891637
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.000541419	0.05411260240891637
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.05411260240891637
RIFT VALLEY FEVER	0.000541419	0.05411260240891637
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.05411260240891637
EBOLA HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.05411260240891637
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.000541419	0.05411260240891637
LUJO HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.05411260240891637
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.05411260240891637
PORPHYRIA VARIEGATA	0.000541419	0.05411260240891637
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.05411260240891637
CLASSIC PHENYLKETONURIA	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.000541419	0.05411260240891637
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.05411260240891637
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.05411260240891637
NASU-HAKOLA DISEASE	0.000541419	0.05411260240891637
WHIPPLE DISEASE	0.000541419	0.05411260240891637
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.05411260240891637
HSD10 DISEASE	0.000541419	0.05411260240891637
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.05411260240891637
WORSTER-DROUGHT SYNDROME	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.05411260240891637
TRIPLE A SYNDROME	0.000541419	0.05411260240891637
EPISODIC ATAXIA TYPE 3	0.000541419	0.05411260240891637
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05411260240891637
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.000541419	0.05411260240891637
DEND SYNDROME	0.000541419	0.05411260240891637
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.000541419	0.05411260240891637
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.05411260240891637
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.05411260240891637
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.000541419	0.05411260240891637
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.05411260240891637
CRONKHITE-CANADA SYNDROME	0.000541419	0.05411260240891637
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.05411260240891637
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.000541419	0.05411260240891637
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.05411260240891637
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.05411260240891637
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.05411260240891637
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.05411260240891637
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.05411260240891637
MAN1B1-CDG	0.000541419	0.05411260240891637
HEREDITARY COPROPORPHYRIA	0.000541419	0.05411260240891637
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.000541419	0.05411260240891637
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.000541419	0.05411260240891637
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.000541419	0.05411260240891637
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.05411260240891637
FAMILIAL THROMBOCYTOSIS	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.05411260240891637
ADIPOSIS DOLOROSA	0.000541419	0.05411260240891637
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.05411260240891637
RABIES	0.000541419	0.05411260240891637
SYSTEMIC SCLEROSIS	0.000541419	0.05411260240891637
GM1 GANGLIOSIDOSIS	0.000541419	0.05411260240891637
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.05411260240891637
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.05411260240891637
PORPHYRIA	0.000541419	0.05411260240891637
PRADER-WILLI SYNDROME	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.000541419	0.05411260240891637
FRAGILE X SYNDROME	0.000541419	0.05411260240891637
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.000541419	0.05411260240891637
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.05411260240891637
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.05411260240891637
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.05411260240891637
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.05411260240891637
INFANTILE REFSUM DISEASE	0.000541419	0.05411260240891637
RETT SYNDROME	0.000541419	0.05411260240891637
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.05411260240891637
ARGININEMIA	0.000541419	0.05411260240891637
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.05411260240891637
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.05411260240891637
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.05411260240891637
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.05411260240891637
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.05411260240891637
ANGELMAN SYNDROME	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.05411260240891637
GRANULOMATOSIS WITH POLYANGIITIS	0.000541419	0.05411260240891637
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.05411260240891637
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.05411260240891637
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.05411260240891637
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.05411260240891637
XERODERMA PIGMENTOSUM	0.000541419	0.05411260240891637
HEREDITARY FOLATE MALABSORPTION	0.000541419	0.05411260240891637
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.05411260240891637
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.000541419	0.05411260240891637
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
SUBEPENDYMOMA	0.000541419	0.05411260240891637
ISOVALERIC ACIDEMIA	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.05411260240891637
PINEOBLASTOMA	0.000541419	0.05411260240891637
MERCURY POISONING	0.000541419	0.05411260240891637
SPONTANEOUS PERIODIC HYPOTHERMIA	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
19P13.12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
GLIOBLASTOMA	0.000541419	0.05411260240891637
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.05411260240891637
MICROSPORIDIOSIS	0.000541419	0.05411260240891637
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.000541419	0.05411260240891637
HYPOPHOSPHATASIA	0.000541419	0.05411260240891637
ALG2-CDG	0.000541419	0.05411260240891637
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.05411260240891637
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.000541419	0.05411260240891637
EPENDYMOMA	0.000541419	0.05411260240891637
ALG1-CDG	0.000541419	0.05411260240891637
NORRIE DISEASE	0.000541419	0.05411260240891637
ECTODERMAL DYSPLASIA SYNDROME	0.000541419	0.05411260240891637
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.05411260240891637
JUVENILE HUNTINGTON DISEASE	0.000541419	0.05411260240891637
NARP SYNDROME	0.000541419	0.05411260240891637
NIEMANN-PICK DISEASE TYPE C	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.000541419	0.05411260240891637
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.05411260240891637
RECURRENT ACUTE PANCREATITIS	0.000541419	0.05411260240891637
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.05411260240891637
ALG9-CDG	0.000541419	0.05411260240891637
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.05411260240891637
FAMILIAL COLORECTAL CANCER TYPE X	0.000541419	0.05411260240891637
MOGS-CDG	0.000541419	0.05411260240891637
NEVUS COMEDONICUS SYNDROME	0.000541419	0.05411260240891637
NEONATAL ADRENOLEUKODYSTROPHY	0.000541419	0.05411260240891637
TAKAYASU ARTERITIS	0.000541419	0.05411260240891637
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.05411260240891637
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.05411260240891637
LHERMITTE-DUCLOS DISEASE	0.000541419	0.05411260240891637
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.05411260240891637
TRISOMY 13	0.000541419	0.05411260240891637
PROLACTINOMA	0.000541419	0.05411260240891637
PARTINGTON SYNDROME	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.05411260240891637
KLEEFSTRA SYNDROME	0.000541419	0.05411260240891637
ADNP SYNDROME	0.000541419	0.05411260240891637
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.05411260240891637
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.000541419	0.05411260240891637
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.05411260240891637
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.05411260240891637
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.05411260240891637
VIRAL HEMORRHAGIC FEVER	0.000541419	0.05411260240891637
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.05411260240891637
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.000541419	0.05411260240891637
20P12.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.05411260240891637
14Q12 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
MPDU1-CDG	0.000541419	0.05411260240891637
THYROCEREBRORENAL SYNDROME	0.000541419	0.05411260240891637
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.000541419	0.05411260240891637
PHACE SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.000541419	0.05411260240891637
DPM1-CDG	0.000541419	0.05411260240891637
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.05411260240891637
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.05411260240891637
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.05411260240891637
ALG3-CDG	0.000541419	0.05411260240891637
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.05411260240891637
HYPERPROLINEMIA TYPE 1	0.000541419	0.05411260240891637
GYRATE ATROPHY OF CHOROID AND RETINA	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.05411260240891637
DYSTONIA-APHONIA SYNDROME	0.000541419	0.05411260240891637
ONDINE SYNDROME	0.000541419	0.05411260240891637
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.05411260240891637
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.05411260240891637
RETT SYNDROME, CONGENITAL VARIANT	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.000541419	0.05411260240891637
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000541419	0.05411260240891637
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.05411260240891637
LISSENCEPHALY 4	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000541419	0.05411260240891637
PERRAULT SYNDROME 3	0.000541419	0.05411260240891637
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.05411260240891637
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.05411260240891637
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000541419	0.05411260240891637
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.05411260240891637
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.000541419	0.05411260240891637
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.05411260240891637
SECKEL SYNDROME 7; SCKL7	0.000541419	0.05411260240891637
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000541419	0.05411260240891637
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000541419	0.05411260240891637
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000541419	0.05411260240891637
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.000541419	0.05411260240891637
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000541419	0.05411260240891637
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.05411260240891637
CHROMOSOME 19P13.13 DELETION SYNDROME	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000541419	0.05411260240891637
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000541419	0.05411260240891637
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000541419	0.05411260240891637
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.05411260240891637
ALZHEIMER DISEASE 3; AD	0.000541419	0.05411260240891637
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.000541419	0.05411260240891637
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000541419	0.05411260240891637
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000541419	0.05411260240891637
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.000541419	0.05411260240891637
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.05411260240891637
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.000541419	0.05411260240891637
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.05411260240891637
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.05411260240891637
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.05411260240891637
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000541419	0.05411260240891637
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.05411260240891637
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.05411260240891637
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.05411260240891637
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000541419	0.05411260240891637
HOLOPROSENCEPHALY 7	0.000541419	0.05411260240891637
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.05411260240891637
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.05411260240891637
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.000541419	0.05411260240891637
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.05411260240891637
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000541419	0.05411260240891637
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000541419	0.05411260240891637
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.000541419	0.05411260240891637
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000541419	0.05411260240891637
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000541419	0.05411260240891637
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000541419	0.05411260240891637
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.05411260240891637
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000541419	0.05411260240891637
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.000541419	0.05411260240891637
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.05411260240891637
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.05411260240891637
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000541419	0.05411260240891637
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.05411260240891637
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000541419	0.05411260240891637
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000541419	0.05411260240891637
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.05411260240891637
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000541419	0.05411260240891637
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.05411260240891637
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.05411260240891637
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.000541419	0.05411260240891637
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.05411260240891637
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.05411260240891637
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000541419	0.05411260240891637
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000541419	0.05411260240891637
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.05411260240891637
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000541419	0.05411260240891637
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.05411260240891637
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.05411260240891637
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.05411260240891637
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.000541419	0.05411260240891637
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000541419	0.05411260240891637
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.05411260240891637
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.05411260240891637
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.000541419	0.05411260240891637
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000541419	0.05411260240891637
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.05411260240891637
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000541419	0.05411260240891637
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.05411260240891637
MIRAGE SYNDROME; MIRAGE	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.05411260240891637
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000541419	0.05411260240891637
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.05411260240891637
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.05411260240891637
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.05411260240891637
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000541419	0.05411260240891637
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000541419	0.05411260240891637
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.05411260240891637
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.000541419	0.05411260240891637
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.05411260240891637
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.05411260240891637
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.05411260240891637
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.05411260240891637
DIAMINOPENTANURIA	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.05411260240891637
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.05411260240891637
GAUCHER DISEASE, TYPE II	0.000541419	0.05411260240891637
GAUCHER DISEASE, TYPE IIIC	0.000541419	0.05411260240891637
BERNARD-SOULIER SYNDROME	0.000541419	0.05411260240891637
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000541419	0.05411260240891637
HARTNUP DISORDER	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.000541419	0.05411260240891637
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
HYPER-BETA-ALANINEMIA	0.000541419	0.05411260240891637
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.05411260240891637
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.05411260240891637
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.05411260240891637
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.05411260240891637
KAPUR-TORIELLO SYNDROME	0.000541419	0.05411260240891637
KEUTEL SYNDROME; KTLS	0.000541419	0.05411260240891637
KRABBE DISEASE	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.000541419	0.05411260240891637
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.05411260240891637
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
KUFOR-RAKEB SYNDROME	0.000541419	0.05411260240891637
ALEXANDER DISEASE	0.000541419	0.05411260240891637
XQ28 (MECP2) DUPLICATION	0.000541419	0.05411260240891637
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.05411260240891637
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.05411260240891637
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.05411260240891637
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.05411260240891637
BRANCHIOOCULOFACIAL SYNDROME	0.000541419	0.05411260240891637
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000541419	0.05411260240891637
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.05411260240891637
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.05411260240891637
DARIER-WHITE DISEASE; DAR	0.000541419	0.05411260240891637
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.05411260240891637
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.05411260240891637
EPILEPSY, READING	0.000541419	0.05411260240891637
FLYNN-AIRD SYNDROME	0.000541419	0.05411260240891637
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.05411260240891637
HUNTINGTON DISEASE; HD	0.000541419	0.05411260240891637
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.05411260240891637
PALLISTER-HALL SYNDROME	0.000541419	0.05411260240891637
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.05411260240891637
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.05411260240891637
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.05411260240891637
PARIETAL FORAMINA	0.000541419	0.05411260240891637
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.05411260240891637
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.05411260240891637
SNEDDON SYNDROME	0.000541419	0.05411260240891637
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.05411260240891637
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.05411260240891637
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.05411260240891637
MACDERMOT-WINTER SYNDROME	0.000541419	0.05411260240891637
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.05411260240891637
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000541419	0.05411260240891637
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 9	0.000541419	0.05411260240891637
MUCOPOLYSACCHARIDOSIS, TYPE II	0.000541419	0.05411260240891637
RETT SYNDROME; RTT	0.000541419	0.05411260240891637
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.05411260240891637
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000541419	0.05411260240891637
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000541419	0.05411260240891637
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.05411260240891637
OCULOECTODERMAL SYNDROME; OES	0.000541419	0.05411260240891637
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.05411260240891637
BAND HETEROTOPIA; BH	0.000541419	0.05411260240891637
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.05411260240891637
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.05411260240891637
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.05411260240891637
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.05411260240891637
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000541419	0.05411260240891637
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.05411260240891637
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.05411260240891637
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.000541419	0.05411260240891637
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.05411260240891637
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS 2	0.000541419	0.05411260240891637
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.05411260240891637
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.05411260240891637
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.05411260240891637
PROPIONIC ACIDEMIA	0.000541419	0.05411260240891637
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.000541419	0.05411260240891637
PHACE ASSOCIATION	0.000541419	0.05411260240891637
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.05411260240891637
HHHH SYNDROME	0.000541419	0.05411260240891637
FABRY DISEASE	0.000541419	0.05411260240891637
THYROCEREBRORETINAL SYNDROME	0.000541419	0.05411260240891637
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.05411260240891637
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.05411260240891637
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.05411260240891637
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.05411260240891637
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.05411260240891637
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000541419	0.05411260240891637
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.05411260240891637
GITELMAN SYNDROME	0.000541419	0.05411260240891637
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.05411260240891637
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.05411260240891637
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.05411260240891637
THREONINEMIA	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000541419	0.05411260240891637
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.05411260240891637
ADRENOLEUKODYSTROPHY	0.000541419	0.05411260240891637
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.05411260240891637
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.000541419	0.05411260240891637
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.000541419	0.05411260240891637
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.05411260240891637
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.000541419	0.05411260240891637
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.05411260240891637
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.05411260240891637
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.05411260240891637
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.000541419	0.05411260240891637
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.05411260240891637
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.05411260240891637
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.05411260240891637
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.05411260240891637
ADULT-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.05411260240891637
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.05411260240891637
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.05411260240891637
ROSAÃ-DORFMAN DISEASE	0.000541419	0.05411260240891637
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.05411260240891637
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.05411260240891637
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.05411260240891637
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.05411260240891637
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.05411260240891637
EAST SYNDROME	0.000541419	0.05411260240891637
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.05411260240891637
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.05411260240891637
KNOBLOCH SYNDROME	0.000541419	0.05411260240891637
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.05411260240891637
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.05411260240891637
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.05411260240891637
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.05411260240891637
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.000541419	0.05411260240891637
FOIX-CHAVANY-MARIE SYNDROME	0.000541419	0.05411260240891637
OPTIC PATHWAY GLIOMA	0.000541419	0.05411260240891637
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.000541419	0.05411260240891637
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.05411260240891637
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.05411260240891637
CRIGLER-NAJJAR SYNDROME	0.000541419	0.05411260240891637
FLYNN-AIRD SYNDROME	0.000541419	0.05411260240891637
DISTAL MONOSOMY 15Q	0.000541419	0.05411260240891637
2P21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.000541419	0.05411260240891637
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.05411260240891637
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.05411260240891637
DISTAL MONOSOMY 7Q36	0.000541419	0.05411260240891637
BEHÃ‡ET DISEASE	0.000541419	0.05411260240891637
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.05411260240891637
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.05411260240891637
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.05411260240891637
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.000541419	0.05411260240891637
LYNCH SYNDROME	0.000541419	0.05411260240891637
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.05411260240891637
XQ21 MICRODELETION SYNDROME	0.000541419	0.05411260240891637
FRONTAL ENCEPHALOCELE	0.000541419	0.05411260240891637
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.05411260240891637
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.000541419	0.05411260240891637
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.05411260240891637
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.05411260240891637
CANAVAN DISEASE	0.000541419	0.05411260240891637
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.05411260240891637
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.05411260240891637
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.05411260240891637
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.05411260240891637
COFS SYNDROME	0.000541419	0.05411260240891637
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.000541419	0.05411260240891637
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.05411260240891637
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.05411260240891637
CONGENITAL DISORDER OF GLYCOSYLATION	0.000541419	0.05411260240891637
MULTIPLE CARBOXYLASE DEFICIENCY	0.000541419	0.05411260240891637
CADASIL	0.000541419	0.05411260240891637
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.05411260240891637
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.05411260240891637
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.05411260240891637
CRYPTOCOCCOSIS	0.000541419	0.05411260240891637
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.05411260240891637
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.05411260240891637
BRANCHIOSKELETOGENITAL SYNDROME	0.000541419	0.05411260240891637
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.05411260240891637
BOWEN-CONRADI SYNDROME	0.000541419	0.05411260240891637
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.000541419	0.05411260240891637
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.000541419	0.05411260240891637
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.05411260240891637
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.05411260240891637
FAMILIAL DYSAUTONOMIA	0.000541419	0.05411260240891637
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000541419	0.05411260240891637
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.05411260240891637
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.05411260240891637
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.05411260240891637
CHÃ‰DIAK-HIGASHI SYNDROME	0.000541419	0.05411260240891637
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.05411260240891637
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.000541419	0.05411260240891637
CENTRAL DIABETES INSIPIDUS	0.000541419	0.05411260240891637
HALL-RIGGS SYNDROME	0.000541419	0.05411260240891637
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.05411260240891637
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.05411260240891637
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000541419	0.05411260240891637
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.05411260240891637
ATAXIA-TELANGIECTASIA	0.000541419	0.05411260240891637
ROMANO-WARD SYNDROME	0.000541419	0.05411260240891637
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.05411260240891637
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.000541419	0.05411260240891637
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000541419	0.05411260240891637
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.000541419	0.05411260240891637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000541419	0.05411260240891637
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.05411260240891637
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.05411260240891637
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.05411260240891637
EPISODIC ATAXIA TYPE 6	0.000541419	0.05411260240891637
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000541419	0.05411260240891637
JOHANSON-BLIZZARD SYNDROME	0.000524934	0.05246499445516708
LEUKOMELANODERMA, INFANTILISM, MENTAL RETARDATION, HYPODONTIA, HYPOTRICHOSIS	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.000524934	0.05246499445516708
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.000524934	0.05246499445516708
LIMB DEFECTS, DISTAL TRANSVERSE, WITH MENTAL RETARDATION AND SPASTICITY	0.000524934	0.05246499445516708
RETINITIS PIGMENTOSA	0.000524934	0.05246499445516708
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.000524934	0.05246499445516708
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.000524934	0.05246499445516708
LAURIN-SANDROW SYNDROME	0.000524934	0.05246499445516708
245800 LAURENCE-MOON SYNDROME	0.000524934	0.05246499445516708
JOHNSON NEUROECTODERMAL SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY, WOLFF TYPE	0.000524934	0.05246499445516708
EEC SYNDROME	0.000524934	0.05246499445516708
CHYLOMICRON RETENTION DISEASE	0.000524934	0.05246499445516708
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 23	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-SPASTICITY-ECTRODACTYLY SYNDROME	0.000524934	0.05246499445516708
LYSINE MALABSORPTION SYNDROME	0.000524934	0.05246499445516708
DE SANCTIS-CACCHIONE SYNDROME	0.000524934	0.05246499445516708
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.000524934	0.05246499445516708
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.000524934	0.05246499445516708
MCDONOUGH SYNDROME	0.000524934	0.05246499445516708
NIEMANN-PICK DISEASE TYPE B	0.000524934	0.05246499445516708
USHER SYNDROME TYPE 1	0.000524934	0.05246499445516708
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.000524934	0.05246499445516708
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000524934	0.05246499445516708
3MC SYNDROME 3	0.000524934	0.05246499445516708
RHOMBENCEPHALOSYNAPSIS	0.000524934	0.05246499445516708
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.000524934	0.05246499445516708
LAMBERT SYNDROME	0.000524934	0.05246499445516708
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.000524934	0.05246499445516708
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.000524934	0.05246499445516708
MEDNIK SYNDROME	0.000524934	0.05246499445516708
WOODHOUSE-SAKATI SYNDROME	0.000524934	0.05246499445516708
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.000524934	0.05246499445516708
ALPORT SYNDROME - INTELLECTUAL DISABILITY - MIDFACE HYPOPLASIA - ELLIPTOCYTOSIS	0.000524934	0.05246499445516708
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.000524934	0.05246499445516708
HYPERURICEMIA, INFANTILE, WITH ABNORMAL BEHAVIOR AND NORMAL HYPOXANTHINEGUANINE PHOSPHORIBOSYLTRANSFERASE	0.000524934	0.05246499445516708
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.000524934	0.05246499445516708
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.05246499445516708
HYPERLYSINURIA WITH HYPERAMMONEMIA	0.000524934	0.05246499445516708
HYPERLYSINEMIA DUE TO DEFECT IN LYSINE TRANSPORT INTO MITOCHONDRIA	0.000524934	0.05246499445516708
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.000524934	0.05246499445516708
HYDROXYPROLINEMIA	0.000524934	0.05246499445516708
HYDROXYLYSINURIA	0.000524934	0.05246499445516708
HYDROXYKYNURENINURIA	0.000524934	0.05246499445516708
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.000524934	0.05246499445516708
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.000524934	0.05246499445516708
ICHTHYOSIS WITH ALOPECIA, ECLABION, ECTROPION, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.000524934	0.05246499445516708
ICHTHYOSIS, MENTAL RETARDATION, DWARFISM, AND RENAL IMPAIRMENT	0.000524934	0.05246499445516708
FETAL IODINE SYNDROME	0.000524934	0.05246499445516708
HYDROXYKYNURENINURIA	0.000524934	0.05246499445516708
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000524934	0.05246499445516708
FETAL ALCOHOL SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 20	0.000524934	0.05246499445516708
RICHARDS-RUNDLE SYNDROME; RRNS	0.000524934	0.05246499445516708
LENNOX-GASTAUT SYNDROME	0.000524934	0.05246499445516708
GALACTOSE EPIMERASE DEFICIENCY	0.000524934	0.05246499445516708
CLASSIC GALACTOSEMIA	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000524934	0.05246499445516708
ARGININOSUCCINIC ACIDURIA	0.000524934	0.05246499445516708
TEMTAMY SYNDROME	0.000524934	0.05246499445516708
PHENOBARBITAL EMBRYOPATHY	0.000524934	0.05246499445516708
INDOLYLACROYL GLYCINURIA WITH MENTAL RETARDATION	0.000524934	0.05246499445516708
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.000524934	0.05246499445516708
IMINOGLYCINURIA	0.000524934	0.05246499445516708
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.000524934	0.05246499445516708
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.000524934	0.05246499445516708
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.000524934	0.05246499445516708
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.000524934	0.05246499445516708
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000524934	0.05246499445516708
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000524934	0.05246499445516708
CHILDHOOD ABSENCE EPILEPSY	0.000524934	0.05246499445516708
DYSOSTEOSCLEROSIS	0.000524934	0.05246499445516708
SACCHAROPINURIA	0.000524934	0.05246499445516708
ROTHMUND-THOMSON SYNDROME	0.000524934	0.05246499445516708
RODRIGUES BLINDNESS	0.000524934	0.05246499445516708
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.000524934	0.05246499445516708
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.000524934	0.05246499445516708
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.000524934	0.05246499445516708
PENDRED SYNDROME	0.000524934	0.05246499445516708
3MC SYNDROME 2	0.000524934	0.05246499445516708
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 3	0.000524934	0.05246499445516708
PSEUDOURIDINURIA AND MENTAL DEFECT	0.000524934	0.05246499445516708
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.000524934	0.05246499445516708
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 4	0.000524934	0.05246499445516708
CARPENTER SYNDROME	0.000524934	0.05246499445516708
MUCOPOLYSACCHARIDOSIS TYPE 1	0.000524934	0.05246499445516708
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.000524934	0.05246499445516708
MUCOLIPIDOSIS TYPE IV	0.000524934	0.05246499445516708
SONODA SYNDROME	0.000524934	0.05246499445516708
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.000524934	0.05246499445516708
MARINESCO-SJÃ–GREN SYNDROME	0.000524934	0.05246499445516708
MUCOPOLYSACCHARIDOSIS TYPE 7	0.000524934	0.05246499445516708
SUCROSURIA, HIATUS HERNIA AND MENTAL RETARDATION	0.000524934	0.05246499445516708
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.000524934	0.05246499445516708
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.000524934	0.05246499445516708
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH MENTAL RETARDATION	0.000524934	0.05246499445516708
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.000524934	0.05246499445516708
TRISOMY 9P	0.000524934	0.05246499445516708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.000524934	0.05246499445516708
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000524934	0.05246499445516708
ALPHA-MANNOSIDOSIS	0.000524934	0.05246499445516708
LAURENCE-MOON SYNDROME	0.000524934	0.05246499445516708
SPINOCEREBELLAR DEGENERATION AND CORNEAL DYSTROPHY	0.000524934	0.05246499445516708
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.000524934	0.05246499445516708
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.000524934	0.05246499445516708
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
NANCE-HORAN SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARESIS, GLAUCOMA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
LARON SYNDROME	0.000524934	0.05246499445516708
SPASTIC DIPLEGIA, INFANTILE TYPE	0.000524934	0.05246499445516708
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.000524934	0.05246499445516708
GROWTH HORMONE INSENSITIVITY SYNDROME	0.000524934	0.05246499445516708
MONILETHRIX	0.000524934	0.05246499445516708
KAPUR-TORIELLO SYNDROME	0.000524934	0.05246499445516708
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 5	0.000524934	0.05246499445516708
OLIVER-MCFARLANE SYNDROME	0.000524934	0.05246499445516708
CHANARIN-DORFMAN SYNDROME	0.000524934	0.05246499445516708
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.000524934	0.05246499445516708
MUCOLIPIDOSIS III ALPHA/BETA	0.000524934	0.05246499445516708
TRYPTOPHANURIA WITH DWARFISM	0.000524934	0.05246499445516708
MORQUIO SYNDROME C	0.000524934	0.05246499445516708
T-SUBSTANCE ANOMALY	0.000524934	0.05246499445516708
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.000524934	0.05246499445516708
NIJMEGEN BREAKAGE SYNDROME	0.000524934	0.05246499445516708
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.000524934	0.05246499445516708
JAWAD SYNDROME	0.000524934	0.05246499445516708
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.000524934	0.05246499445516708
MICROCEPHALY-CARDIOMYOPATHY	0.000524934	0.05246499445516708
PROLIDASE DEFICIENCY	0.000524934	0.05246499445516708
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000524934	0.05246499445516708
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000524934	0.05246499445516708
TYROSINE TRANSAMINASE DEFICIENCY	0.000524934	0.05246499445516708
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000524934	0.05246499445516708
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000524934	0.05246499445516708
JUBERG-HAYWARD SYNDROME	0.000524934	0.05246499445516708
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000524934	0.05246499445516708
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.000524934	0.05246499445516708
PALLISTER-HALL SYNDROME	0.000524934	0.05246499445516708
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.000524934	0.05246499445516708
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.000524934	0.05246499445516708
LOWRY-WOOD SYNDROME	0.000524934	0.05246499445516708
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.000524934	0.05246499445516708
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.000524934	0.05246499445516708
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.000524934	0.05246499445516708
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME III	0.000524934	0.05246499445516708
OLIVER SYNDROME	0.000524934	0.05246499445516708
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.000524934	0.05246499445516708
3C SYNDROME	0.000524934	0.05246499445516708
OCULORENOCEREBELLAR SYNDROME	0.000524934	0.05246499445516708
PENDRED SYNDROME	0.000524934	0.05246499445516708
OCULOPALATOCEREBRAL SYNDROME	0.000524934	0.05246499445516708
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.000524934	0.05246499445516708
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.000524934	0.05246499445516708
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000524934	0.05246499445516708
JUNG SYNDROME	0.000524934	0.05246499445516708
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000524934	0.05246499445516708
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.000524934	0.05246499445516708
HOOFT DISEASE	0.000524934	0.05246499445516708
ACRODYSOSTOSIS	0.000524934	0.05246499445516708
MEGALENCEPHALY	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.000524934	0.05246499445516708
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.000524934	0.05246499445516708
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000524934	0.05246499445516708
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000524934	0.05246499445516708
LENTIGINOSIS, CENTROFACIAL NEURODYSRAPHIC	0.000524934	0.05246499445516708
LARYNGEAL ABDUCTOR PARALYSIS	0.000524934	0.05246499445516708
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.000524934	0.05246499445516708
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.000524934	0.05246499445516708
FRYNS-SMEETS-THIRY SYNDROME	0.000524934	0.05246499445516708
HYPOCHONDROPLASIA	0.000524934	0.05246499445516708
EDINBURGH MALFORMATION SYNDROME	0.000524934	0.05246499445516708
ADULT POLYGLUCOSAN BODY DISEASE	0.000524934	0.05246499445516708
HOLOPROSENCEPHALY 3; HPE3	0.000524934	0.05246499445516708
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.000524934	0.05246499445516708
FAMILIAL THYROID DYSHORMONOGENESIS	0.000524934	0.05246499445516708
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.000524934	0.05246499445516708
FRONTONASAL DYSPLASIA 1; FND1	0.000524934	0.05246499445516708
GEMIGNANI SYNDROME	0.000524934	0.05246499445516708
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.000524934	0.05246499445516708
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.000524934	0.05246499445516708
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.000524934	0.05246499445516708
MENTAL AND GROWTH RETARDATION WITH AMBLYOPIA	0.000524934	0.05246499445516708
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.000524934	0.05246499445516708
HURLER SYNDROME	0.000524934	0.05246499445516708
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.000524934	0.05246499445516708
VELOCARDIOFACIAL SYNDROME	0.000524934	0.05246499445516708
CLEFT PALATE-SHORT STATURE-VERTEBRAL ANOMALIES SYNDROME	0.000524934	0.05246499445516708
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000524934	0.05246499445516708
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000524934	0.05246499445516708
THUMB DEFORMITY AND ALOPECIA	0.000524934	0.05246499445516708
TELECANTHUS	0.000524934	0.05246499445516708
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA WITH PRECOCIOUS PUBERTY	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.000524934	0.05246499445516708
RUVALCABA SYNDROME	0.000524934	0.05246499445516708
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.000524934	0.05246499445516708
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.05246499445516708
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME V; OFD5	0.000524934	0.05246499445516708
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.000524934	0.05246499445516708
FLOATING-HARBOR SYNDROME	0.000524934	0.05246499445516708
OPHTHALMOPLEGIA, PROGRESSIVE, WITH SCROTAL TONGUE AND MENTAL DEFICIENCY	0.000524934	0.05246499445516708
FIBULAR HEMIMELIA	0.000524934	0.05246499445516708
HEMIFACIAL MICROSOMIA	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.000524934	0.05246499445516708
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.000524934	0.05246499445516708
19Q13.11 MICRODELETION SYNDROME	0.000524934	0.05246499445516708
HOMOCARNOSINOSIS	0.000524934	0.05246499445516708
7Q11.23 DUPLICATION SYNDROME	0.000524934	0.05246499445516708
15Q24 RECURRENT MICRODELETION SYNDROME	0.000524934	0.05246499445516708
ATR-16 SYNDROME	0.000524934	0.05246499445516708
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.05246499445516708
17Q21.31 RECURRENT MICRODELETION SYNDROME	0.000524934	0.05246499445516708
PRADER-WILLI SYNDROME (TYPE 2)	0.000524934	0.05246499445516708
9Q SUBTELOMERIC DELETION SYNDROME	0.000524934	0.05246499445516708
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA TYPE 2	0.000524934	0.05246499445516708
2Q37 MONOSOMY	0.000524934	0.05246499445516708
49,XYYYY SYNDROME	0.000524934	0.05246499445516708
MYOTONIA PERMANENS	0.000524934	0.05246499445516708
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.000524934	0.05246499445516708
CAT-EYE SYNDROME (TYPE I)	0.000524934	0.05246499445516708
8P23.1 DELETION SYNDROME	0.000524934	0.05246499445516708
LIG4 SYNDROME	0.000524934	0.05246499445516708
WAGR 11P13 DELETION SYNDROME	0.000524934	0.05246499445516708
22Q11 DUPLICATION SYNDROME	0.000524934	0.05246499445516708
WILLIAMS-BEUREN SYNDROME (WBS)	0.000524934	0.05246499445516708
22Q13 DELETION SYNDROME (PHELAN-MCDERMID SYNDROME)	0.000524934	0.05246499445516708
TRANSIENT NEONATAL DIABETES MELLITUS	0.000524934	0.05246499445516708
CRI DU CHAT SYNDROME (5P DELETION)	0.000524934	0.05246499445516708
NF1-MICRODELETION SYNDROME	0.000524934	0.05246499445516708
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.000524934	0.05246499445516708
1Q21.1 RECURRENT MICRODUPLICATION (POSSIBLE SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.000524934	0.05246499445516708
SPINOCEREBELLAR ATAXIA TYPE 21	0.000524934	0.05246499445516708
16P11.2-P12.2 MICRODELETION SYNDROME	0.000524934	0.05246499445516708
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.000524934	0.05246499445516708
IRIDA SYNDROME	0.000524934	0.05246499445516708
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.000524934	0.05246499445516708
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.000524934	0.05246499445516708
DYSTONIA 16	0.000524934	0.05246499445516708
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.000524934	0.05246499445516708
%112350 WEISMANN-NETTER SYNDROME; WNS;;BOWING OF LEGS, ANTERIOR, WITH DWARFISM;;TOXOPACHYOSTEOSE DIAPHYSAIRE TIBIO-PERONIERE	0.000524934	0.05246499445516708
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.05246499445516708
BASAL CELL NEVUS SYNDROME	0.000524934	0.05246499445516708
HYPERTRICHOSIS-ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000524934	0.05246499445516708
FAMILIAL PAROXYSMAL ATAXIA	0.000524934	0.05246499445516708
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.000524934	0.05246499445516708
TOWNES-BROCKS SYNDROME 1; TBS1	0.000524934	0.05246499445516708
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.000524934	0.05246499445516708
HALLERMANN-STREIFF SYNDROME	0.000524934	0.05246499445516708
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.000524934	0.05246499445516708
8P23.1 DUPLICATION SYNDROME	0.000524934	0.05246499445516708
SMITH-MAGENIS SYNDROME	0.000524934	0.05246499445516708
12Q14 MICRODELETION SYNDROME	0.000524934	0.05246499445516708
22Q11.2 DISTAL DELETION SYNDROME	0.000524934	0.05246499445516708
2P15-16.1 MICRODELETION SYNDROME	0.000524934	0.05246499445516708
STICKLER SYNDROME TYPE 1	0.000524934	0.05246499445516708
OTOPALATODIGITAL SYNDROME TYPE 2	0.000524934	0.05246499445516708
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.000524934	0.05246499445516708
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000524934	0.05246499445516708
DYSAUTONOMIA-LIKE DISORDER	0.000524934	0.05246499445516708
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.000524934	0.05246499445516708
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.000524934	0.05246499445516708
DICARBOXYLICAMINO ACIDURIA	0.000524934	0.05246499445516708
DIBASIC AMINO ACIDURIA I	0.000524934	0.05246499445516708
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.000524934	0.05246499445516708
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000524934	0.05246499445516708
DEXTROCARDIA WITH UNUSUAL FACIES AND MICROPHTHALMIA	0.000524934	0.05246499445516708
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000524934	0.05246499445516708
DERMATOLEUKODYSTROPHY	0.000524934	0.05246499445516708
SPONDYLO-OCULAR SYNDROME	0.000524934	0.05246499445516708
WILSON DISEASE	0.000524934	0.05246499445516708
DYSSPONDYLOENCHONDROMATOSIS	0.000524934	0.05246499445516708
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.000524934	0.05246499445516708
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.000524934	0.05246499445516708
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.000524934	0.05246499445516708
DEAFNESS AND MYOPIA; DFNMYP	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.000524934	0.05246499445516708
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.000524934	0.05246499445516708
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
CYSTEINE PEPTIDURIA	0.000524934	0.05246499445516708
CUTIS VERTICIS GYRATA AND MENTAL DEFICIENCY	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 16, X-LINKED	0.000524934	0.05246499445516708
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.000524934	0.05246499445516708
ELLIS-VAN CREVELD SYNDROME	0.000524934	0.05246499445516708
ENCEPHALOMALACIA, MULTILOCULAR	0.000524934	0.05246499445516708
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.000524934	0.05246499445516708
HISTIDINEMIA	0.000524934	0.05246499445516708
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.000524934	0.05246499445516708
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000524934	0.05246499445516708
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.000524934	0.05246499445516708
FACIOCARDIORENAL SYNDROME	0.000524934	0.05246499445516708
GLUTATHIONURIA	0.000524934	0.05246499445516708
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
TUBEROUS SCLEROSIS COMPLEX	0.000524934	0.05246499445516708
SECKEL SYNDROME	0.000524934	0.05246499445516708
GERODERMA OSTEODYSPLASTICUM; GO	0.000524934	0.05246499445516708
ICF SYNDROME	0.000524934	0.05246499445516708
HYPOTRICHOSIS-INTELLECTUAL DISABILITY, LOPES TYPE	0.000524934	0.05246499445516708
GALACTOSEMIA	0.000524934	0.05246499445516708
OCCIPITAL HORN SYNDROME	0.000524934	0.05246499445516708
FORMIMINOTRANSFERASE DEFICIENCY	0.000524934	0.05246499445516708
FETAL IODINE DEFICIENCY DISORDER	0.000524934	0.05246499445516708
FANCONI ANEMIA	0.000524934	0.05246499445516708
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.000524934	0.05246499445516708
226440 EPIDERMOLYSIS BULLOSA, LATE-ONSET LOCALIZED JUNCTIONAL, WITH MENTALRETARDATION	0.000524934	0.05246499445516708
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.000524934	0.05246499445516708
218300 CRANIODIAPHYSEAL DYSPLASIA; CDD	0.000524934	0.05246499445516708
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.000524934	0.05246499445516708
APERT SYNDROME	0.000524934	0.05246499445516708
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.000524934	0.05246499445516708
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.000524934	0.05246499445516708
207790 ARACHNOID CYSTS, INTRACRANIAL	0.000524934	0.05246499445516708
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.000524934	0.05246499445516708
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.000524934	0.05246499445516708
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.000524934	0.05246499445516708
GILLESPIE SYNDROME; GLSP	0.000524934	0.05246499445516708
WAGR SYNDROME	0.000524934	0.05246499445516708
WAARDENBURG SYNDROME TYPE 3	0.000524934	0.05246499445516708
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.000524934	0.05246499445516708
AMINO ACIDURIA WITH MENTAL DEFICIENCY, DWARFISM, MUSCULAR DYSTROPHY,OSTEOPOROSIS, AND ACIDOSIS	0.000524934	0.05246499445516708
MALE HYPERGONADOTROPIC HYPOGONADISM-INTELLECTUAL DISABILITY-SKELETAL ANOMALIES SYNDROME	0.000524934	0.05246499445516708
LEBER CONGENITAL AMAUROSIS, TYPE II	0.000524934	0.05246499445516708
LEBER CONGENITAL AMAUROSIS, TYPE I	0.000524934	0.05246499445516708
ALPHA-METHYLACETOACETIC ACIDURIA	0.000524934	0.05246499445516708
AGENESIS OF CEREBRAL WHITE MATTER	0.000524934	0.05246499445516708
HYPERTRICHOSIS CUBITI	0.000524934	0.05246499445516708
ACHALASIA-MICROCEPHALY SYNDROME	0.000524934	0.05246499445516708
WILLIAMS SYNDROME	0.000524934	0.05246499445516708
DOWN SYNDROME	0.000524934	0.05246499445516708
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.000524934	0.05246499445516708
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000524934	0.05246499445516708
AURAL ATRESIA, MULTIPLE CONGENITAL ANOMALIES, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
CHARGE SYNDROME	0.000524934	0.05246499445516708
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.000524934	0.05246499445516708
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.000524934	0.05246499445516708
HSD10 DISEASE, ATYPICAL TYPE	0.000524934	0.05246499445516708
CEPHALIN LIPIDOSIS	0.000524934	0.05246499445516708
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000524934	0.05246499445516708
CARNOSINEMIA	0.000524934	0.05246499445516708
CARDIOMYOPATHY, DILATED, WITH HYPERGONADOTROPIC HYPOGONADISM	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.000524934	0.05246499445516708
CAHMR SYNDROME	0.000524934	0.05246499445516708
%211390 SABINAS BRITTLE HAIR SYNDROME;;BRITTLE HAIR AND MENTAL DEFICIT	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY-RETINITIS PIGMENTOSA SYNDROME	0.000524934	0.05246499445516708
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000524934	0.05246499445516708
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000524934	0.05246499445516708
BIEMOND SYNDROME II	0.000524934	0.05246499445516708
TOWNES-BROCKS SYNDROME	0.000524934	0.05246499445516708
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000524934	0.05246499445516708
BEHR SYNDROME	0.000524934	0.05246499445516708
BARBER-SAY SYNDROME; BBRSAY	0.000524934	0.05246499445516708
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.000524934	0.05246499445516708
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.000524934	0.05246499445516708
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000524934	0.05246499445516708
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.000524934	0.05246499445516708
BAMFORTH-LAZARUS SYNDROME	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 16; BBS16	0.000524934	0.05246499445516708
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 14; BBS14	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 13; BBS13	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 9; BBS9	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 8; BBS8	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 7; BBS7	0.000524934	0.05246499445516708
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 4; BBS4	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 2	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.000524934	0.05246499445516708
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.000524934	0.05246499445516708
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.000524934	0.05246499445516708
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.000524934	0.05246499445516708
NEPHRONOPHTHISIS 18; NPHP18	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 19; BBS19	0.000524934	0.05246499445516708
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000524934	0.05246499445516708
N SYNDROME	0.000524934	0.05246499445516708
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000524934	0.05246499445516708
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000524934	0.05246499445516708
OSTEOGLOSPHONIC DYSPLASIA	0.000524934	0.05246499445516708
MYOCLONIC-ATONIC EPILEPSY	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.000524934	0.05246499445516708
XQ12-Q13.3 DUPLICATION SYNDROME	0.000524934	0.05246499445516708
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000524934	0.05246499445516708
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.000524934	0.05246499445516708
TRICHOTHIODYSTROPHY 2, PHOTOSENSITIVE	0.000524934	0.05246499445516708
CHOPS SYNDROME; CHOPS	0.000524934	0.05246499445516708
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.000524934	0.05246499445516708
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.000524934	0.05246499445516708
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000524934	0.05246499445516708
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
ERYTHROKERATODERMIA VARIABILIS	0.000524934	0.05246499445516708
CEREBELLOFACIODENTAL SYNDROME	0.000524934	0.05246499445516708
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000524934	0.05246499445516708
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.000524934	0.05246499445516708
ATKIN-FLAITZ SYNDROME	0.000524934	0.05246499445516708
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000524934	0.05246499445516708
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.000524934	0.05246499445516708
BJÃ–RNSTAD SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000524934	0.05246499445516708
SECKEL SYNDROME 8; SCKL8	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000524934	0.05246499445516708
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000524934	0.05246499445516708
HEART-HAND SYNDROME TYPE 2	0.000524934	0.05246499445516708
16P13.11 MICRODUPLICATION SYNDROME	0.000524934	0.05246499445516708
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.000524934	0.05246499445516708
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.000524934	0.05246499445516708
CARNOSINASE DEFICIENCY	0.000524934	0.05246499445516708
URBAN-ROGERS-MEYER SYNDROME	0.000524934	0.05246499445516708
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000524934	0.05246499445516708
VACTERL WITH HYDROCEPHALUS	0.000524934	0.05246499445516708
VAN DEN BOSCH SYNDROME	0.000524934	0.05246499445516708
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000524934	0.05246499445516708
MMEP SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.000524934	0.05246499445516708
%614329 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 31; MRT31	0.000524934	0.05246499445516708
FEINGOLD SYNDROME 2; FGLDS2	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 11; MRD11	0.000524934	0.05246499445516708
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 10; MRD10	0.000524934	0.05246499445516708
CHARGE SYNDROME	0.000524934	0.05246499445516708
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.000524934	0.05246499445516708
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.000524934	0.05246499445516708
WEISMANN-NETTER SYNDROME	0.000524934	0.05246499445516708
ARTERIAL TORTUOSITY SYNDROME	0.000524934	0.05246499445516708
AYMÃ‰-GRIPP SYNDROME	0.000524934	0.05246499445516708
BARTSOCAS-PAPAS SYNDROME	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000524934	0.05246499445516708
ABETAL34V AMYLOIDOSIS	0.000524934	0.05246499445516708
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.000524934	0.05246499445516708
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000524934	0.05246499445516708
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.000524934	0.05246499445516708
MICROPHTHALMIA, SYNDROMIC 12	0.000524934	0.05246499445516708
LAMBERT SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.000524934	0.05246499445516708
NOONAN SYNDROME 8; NS8	0.000524934	0.05246499445516708
FEINGOLD SYNDROME	0.000524934	0.05246499445516708
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.000524934	0.05246499445516708
MICROCEPHALY - INTELLECTUAL DISABILITY - PHALANGEAL AND NEUROLOGICAL ANOMALIES	0.000524934	0.05246499445516708
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000524934	0.05246499445516708
HOYERAAL-HREIDARSSON SYNDROME	0.000524934	0.05246499445516708
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.000524934	0.05246499445516708
FARBER DISEASE	0.000524934	0.05246499445516708
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000524934	0.05246499445516708
PROTEUS-LIKE SYNDROME	0.000524934	0.05246499445516708
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000524934	0.05246499445516708
CONGENITAL VARICELLA SYNDROME	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME TYPE 5	0.000524934	0.05246499445516708
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.000524934	0.05246499445516708
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.000524934	0.05246499445516708
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.000524934	0.05246499445516708
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000524934	0.05246499445516708
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, MKB TYPE	0.000524934	0.05246499445516708
3MC SYNDROME	0.000524934	0.05246499445516708
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000524934	0.05246499445516708
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000524934	0.05246499445516708
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME TYPE 4	0.000524934	0.05246499445516708
MECKEL SYNDROME 13; MKS13	0.000524934	0.05246499445516708
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000524934	0.05246499445516708
RAHMAN SYNDROME	0.000524934	0.05246499445516708
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000524934	0.05246499445516708
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000524934	0.05246499445516708
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 19; BMIQ19	0.000524934	0.05246499445516708
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA-GLAUCOMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.000524934	0.05246499445516708
CARDIAC-UROGENITAL SYNDROME; CUGS	0.000524934	0.05246499445516708
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.000524934	0.05246499445516708
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.000524934	0.05246499445516708
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.000524934	0.05246499445516708
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.000524934	0.05246499445516708
OSTEOPETROSIS AND RELATED DISORDERS	0.000524934	0.05246499445516708
SHORT STATURE-WEBBED NECK-HEART DISEASE SYNDROME	0.000524934	0.05246499445516708
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.000524934	0.05246499445516708
PFEIFFER-PALM-TELLER SYNDROME	0.000524934	0.05246499445516708
FRAXE INTELLECTUAL DISABILITY	0.000524934	0.05246499445516708
PIEBALDISM	0.000524934	0.05246499445516708
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.000524934	0.05246499445516708
ELLIS VAN CREVELD SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000524934	0.05246499445516708
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.000524934	0.05246499445516708
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000524934	0.05246499445516708
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.000524934	0.05246499445516708
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.000524934	0.05246499445516708
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000524934	0.05246499445516708
STRIATAL DEGENERATION, AUTOSOMAL DOMINANT 2	0.000524934	0.05246499445516708
PTEN HAMARTOMA TUMOR SYNDROME	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.000524934	0.05246499445516708
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.000524934	0.05246499445516708
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.000524934	0.05246499445516708
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000524934	0.05246499445516708
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000524934	0.05246499445516708
CHROMOSOME 15Q14 DELETION SYNDROME	0.000524934	0.05246499445516708
COSTELLO SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-SHORT STATURE-HYPERTELORISM SYNDROME	0.000524934	0.05246499445516708
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.000524934	0.05246499445516708
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.000524934	0.05246499445516708
MEIER-GORLIN SYNDROME 6; MGORS6	0.000524934	0.05246499445516708
UNVERRICHT-LUNDBORG DISEASE	0.000524934	0.05246499445516708
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.000524934	0.05246499445516708
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000524934	0.05246499445516708
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.000524934	0.05246499445516708
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.000524934	0.05246499445516708
OCULOFACIOCARDIODENTAL SYNDROME	0.000524934	0.05246499445516708
PENTASOMY X	0.000524934	0.05246499445516708
THUMB STIFFNESS-BRACHYDACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
PSEUDOPROGERIA SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 59	0.000524934	0.05246499445516708
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000524934	0.05246499445516708
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000524934	0.05246499445516708
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.000524934	0.05246499445516708
SOTOS SYNDROME 3	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 56	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 54	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 20	0.000524934	0.05246499445516708
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.000524934	0.05246499445516708
PYRIDOXINE-DEPENDENT EPILEPSY	0.000524934	0.05246499445516708
PRADER-WILLI SYNDROME (TYPE 1)	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000524934	0.05246499445516708
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.000524934	0.05246499445516708
OCULO-PALATO-CEREBRAL SYNDROME	0.000524934	0.05246499445516708
CEREBROCOSTOMANDIBULAR SYNDROME	0.000524934	0.05246499445516708
CEREBROFACIOTHORACIC DYSPLASIA	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 53	0.000524934	0.05246499445516708
MONOSOMY 18P	0.000524934	0.05246499445516708
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 3; BBS3	0.000524934	0.05246499445516708
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.000524934	0.05246499445516708
MCDONOUGH SYNDROME	0.000524934	0.05246499445516708
MATTHEW-WOOD SYNDROME	0.000524934	0.05246499445516708
MASA SYNDROME	0.000524934	0.05246499445516708
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.000524934	0.05246499445516708
LEBER OPTIC ATROPHY AND DYSTONIA	0.000524934	0.05246499445516708
VAN DEN BOSCH SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.000524934	0.05246499445516708
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.000524934	0.05246499445516708
SCARF SYNDROME	0.000524934	0.05246499445516708
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.000524934	0.05246499445516708
SHPRINTZEN-GOLDBERG SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.000524934	0.05246499445516708
OPTIC ATROPHY 2	0.000524934	0.05246499445516708
COWCHOCK SYNDROME; COWCK	0.000524934	0.05246499445516708
N SYNDROME	0.000524934	0.05246499445516708
MARDEN-WALKER SYNDROME	0.000524934	0.05246499445516708
LYSINURIC PROTEIN INTOLERANCE	0.000524934	0.05246499445516708
LOWRY-MACLEAN SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 14	0.000524934	0.05246499445516708
MEGALENCEPHALY	0.000524934	0.05246499445516708
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.000524934	0.05246499445516708
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.000524934	0.05246499445516708
ANE SYNDROME	0.000524934	0.05246499445516708
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.000524934	0.05246499445516708
DISTAL MONOSOMY 10P	0.000524934	0.05246499445516708
HUNTER-MCALPINE CRANIOSYNOSTOSIS SYNDROME	0.000524934	0.05246499445516708
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.000524934	0.05246499445516708
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000524934	0.05246499445516708
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.000524934	0.05246499445516708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, MICROMELIC	0.000524934	0.05246499445516708
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.000524934	0.05246499445516708
ICHTHYOSIS-MENTAL RETARDATION SYNDROME WITH LARGE KERATOHYALIN GRANULES IN THE SKIN	0.000524934	0.05246499445516708
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.000524934	0.05246499445516708
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.000524934	0.05246499445516708
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000524934	0.05246499445516708
MONOSOMY 13Q14	0.000524934	0.05246499445516708
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.000524934	0.05246499445516708
CONE-ROD DYSTROPHY 1; CORD1	0.000524934	0.05246499445516708
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.000524934	0.05246499445516708
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000524934	0.05246499445516708
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.000524934	0.05246499445516708
MENTAL RETARDATION WITH SPASTIC PARAPLEGIA	0.000524934	0.05246499445516708
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.000524934	0.05246499445516708
KID SYNDROME	0.000524934	0.05246499445516708
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 97; MRX97	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 95	0.000524934	0.05246499445516708
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.000524934	0.05246499445516708
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.000524934	0.05246499445516708
BRUNNER SYNDROME; BRNRS	0.000524934	0.05246499445516708
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000524934	0.05246499445516708
CHROMOSOME XP11.3 DELETION SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.000524934	0.05246499445516708
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.000524934	0.05246499445516708
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 84	0.000524934	0.05246499445516708
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000524934	0.05246499445516708
TRISOMY 12P	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 77	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 46	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 81	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 63	0.000524934	0.05246499445516708
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000524934	0.05246499445516708
JOUBERT SYNDROME 10	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 92	0.000524934	0.05246499445516708
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000524934	0.05246499445516708
MASA SYNDROME	0.000524934	0.05246499445516708
LESCH-NYHAN PHENOTYPE WITH NORMAL HGPRT	0.000524934	0.05246499445516708
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.000524934	0.05246499445516708
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
HYPOGONADISM, MALE, WITH MENTAL RETARDATION AND SKELETAL ANOMALIES	0.000524934	0.05246499445516708
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.000524934	0.05246499445516708
DISTAL MONOSOMY 9P	0.000524934	0.05246499445516708
FOCAL DERMAL HYPOPLASIA; FDH	0.000524934	0.05246499445516708
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000524934	0.05246499445516708
CUTIS VERTICIS GYRATA, THYROID APLASIA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 2	0.000524934	0.05246499445516708
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.000524934	0.05246499445516708
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.000524934	0.05246499445516708
MICROPHTHALMIA, SYNDROMIC 4	0.000524934	0.05246499445516708
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.000524934	0.05246499445516708
DERMATOLEUKODYSTROPHY	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000524934	0.05246499445516708
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, X-LINKED 105; MRX105	0.000524934	0.05246499445516708
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000524934	0.05246499445516708
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.000524934	0.05246499445516708
GRANGE SYNDROME; GRNG	0.000524934	0.05246499445516708
FRONTONASAL DYSPLASIA	0.000524934	0.05246499445516708
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
EAR-PATELLA-SHORT STATURE SYNDROME	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME XI; OFD11	0.000524934	0.05246499445516708
FACIOCARDIOMELIC SYNDROME	0.000524934	0.05246499445516708
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000524934	0.05246499445516708
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.000524934	0.05246499445516708
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.000524934	0.05246499445516708
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
LELIS SYNDROME	0.000524934	0.05246499445516708
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.000524934	0.05246499445516708
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.000524934	0.05246499445516708
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000524934	0.05246499445516708
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000524934	0.05246499445516708
OTOMANDIBULAR SYNDROME	0.000524934	0.05246499445516708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000524934	0.05246499445516708
BIEMOND SYNDROME TYPE 2	0.000524934	0.05246499445516708
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.000524934	0.05246499445516708
DESBUQUOIS SYNDROME	0.000524934	0.05246499445516708
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.000524934	0.05246499445516708
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.000524934	0.05246499445516708
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.000524934	0.05246499445516708
MIETENS SYNDROME	0.000524934	0.05246499445516708
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.000524934	0.05246499445516708
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.000524934	0.05246499445516708
PROPIONIC ACIDEMIA	0.000524934	0.05246499445516708
PERIORAL MYOCLONIA WITH ABSENCES	0.000524934	0.05246499445516708
ISOLATED PLAGIOCEPHALY	0.000524934	0.05246499445516708
ISOLATED BRACHYCEPHALY	0.000524934	0.05246499445516708
CHROMOSOME 13Q14 DELETION SYNDROME	0.000524934	0.05246499445516708
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000524934	0.05246499445516708
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000524934	0.05246499445516708
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.000524934	0.05246499445516708
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.000524934	0.05246499445516708
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.000524934	0.05246499445516708
BETA-UREIDOPROPIONASE DEFICIENCY	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000524934	0.05246499445516708
ATTENUATED CHÃ‰DIAK-HIGASHI SYNDROME	0.000524934	0.05246499445516708
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.000524934	0.05246499445516708
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.000524934	0.05246499445516708
COENZYME Q10 DEFICIENCY	0.000524934	0.05246499445516708
ALDH18A1-RELATED DE BARSY SYNDROME	0.000524934	0.05246499445516708
FRONTONASAL DYSPLASIA 2; FND2	0.000524934	0.05246499445516708
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
MUSCULAR DYSTROPHY, CONGENITAL, DUE TO INTEGRIN ALPHA-7 DEFICIENCY	0.000524934	0.05246499445516708
ALOPECIA-MENTAL RETARDATION SYNDROME 2	0.000524934	0.05246499445516708
RING CHROMOSOME 8 SYNDROME	0.000524934	0.05246499445516708
ACROGERIA	0.000524934	0.05246499445516708
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.000524934	0.05246499445516708
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.000524934	0.05246499445516708
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
HURLER SYNDROME	0.000524934	0.05246499445516708
CREE MENTAL RETARDATION SYNDROME	0.000524934	0.05246499445516708
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.000524934	0.05246499445516708
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.000524934	0.05246499445516708
CURRY-JONES SYNDROME	0.000524934	0.05246499445516708
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.000524934	0.05246499445516708
MACROCEPHALY/AUTISM SYNDROME	0.000524934	0.05246499445516708
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.000524934	0.05246499445516708
BARDET-BIEDL SYNDROME 6; BBS6	0.000524934	0.05246499445516708
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.000524934	0.05246499445516708
NEUROFERRITINOPATHY	0.000524934	0.05246499445516708
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.000524934	0.05246499445516708
HYPOCHONDROPLASIA	0.000524934	0.05246499445516708
X-LINKED ADRENOLEUKODYSTROPHY	0.000524934	0.05246499445516708
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.000524934	0.05246499445516708
OROFACIODIGITAL SYNDROME TYPE 14	0.000524934	0.05246499445516708
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.000524934	0.05246499445516708
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.000524934	0.05246499445516708
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000524934	0.05246499445516708
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.000524934	0.05246499445516708
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.000524934	0.05246499445516708
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.000524934	0.05246499445516708
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.000524934	0.05246499445516708
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000524934	0.05246499445516708
GOLDENHAR SYNDROME	0.000524934	0.05246499445516708
GORLIN SYNDROME	0.000524934	0.05246499445516708
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.000524934	0.05246499445516708
HIRSCHSPRUNG DISEASE	0.000524934	0.05246499445516708
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.000524934	0.05246499445516708
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.000524934	0.05246499445516708
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.000524934	0.05246499445516708
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.000524934	0.05246499445516708
COOPER-JABS SYNDROME	0.000524934	0.05246499445516708
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.000524934	0.05246499445516708
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.000524934	0.05246499445516708
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.000524934	0.05246499445516708
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000524934	0.05246499445516708
CRANIODIAPHYSEAL DYSPLASIA	0.000524934	0.05246499445516708
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.000524934	0.05246499445516708
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.000524934	0.05246499445516708
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.000524934	0.05246499445516708
